Medacta Corporate
 GMK Sphere awarded 5A ODEP rating, confirming excellent survival rate of the implant

GMK Sphere awarded 5A ODEP rating, confirming excellent survival rate of the implant

Medacta’s commitment to providing innovative and safe products is coming to fruition! According to the Orthopaedic Data Evaluation Panel (ODEP) rating criteria, Medacta’s GMK Sphere knee has been evaluated in a minimum cohort of 250 knees at 5 years, demonstrating Kaplan-Meier survivorship data in line with the highest ODEP standards for total knee arthroplasty.

Read more >

Please note that the ODEP rating is not awarded based only on a specific study (with selected surgeons), but from nationwide data of English and Welsh hospitals. GMK Sphere revision rate is in line with the requirements for 5A* ODEP rating. However, the number of patients at 5-year follow up included in the analysis is still not sufficient to achieve this rating.
 
The GMK Sphere results are on the right track to be awarded the highest ODEP rating of 13A*!
See more by visiting the ODEP site at http://www.odep.org.uk/
 
Want to know more about the GMK Sphere and the growing popularity of the medially stabilized concept? Contact your sales associate today and attend an upcoming Learning Center!
 
Read more on GMK Sphere.
BECKER’S ASC REVIEW: Economic Advantages of Medacta’s Sterile-packed, GMK® Efficiency Single-use Instruments for Total Knee Arthroplasty, by Tyler Goldberg, MDa; Jason A. Inzana, PhDb, John A. Maltry, MDc

BECKER’S ASC REVIEW: Economic Advantages of Medacta’s Sterile-packed, GMK® Efficiency Single-use Instruments for Total Knee Arthroplasty, by Tyler Goldberg, MDa; Jason A. Inzana, PhDb, John A. Maltry, MDc

GMK Efficiency single-use instrumentation can facilitate time and cost savings while bringing greater reliability and predictability to multiple steps in the global delivery of TKA. In this study is highlighted that, switching from reusable to Efficiency instruments, approximately 75% of simulated healthcare providers saved at least $750 per case, 50% saved at least $1,000 per case, and 25% saved over $1,200 per case.

Read more >
Total knee arthroplasty (TKA) is well established as a clinically successful and cost-effective procedure for alleviating pain, restoring function and enabling a higher quality of life for patients with advanced osteoarthritis. These positive outcomes have driven significant growth in the number of TKA procedures performed globally. In the United States alone, the number of procedures is projected to increase from 693,400 cases in 2010 to 3.5 million cases by 20301,2.
 
Driven by such a significant projected boost of TKA, providers must evaluate all aspects of these procedures to ensure financial viability while delivering high quality care. In turn, there is a strong focus on controlling operating costs, minimising post-discharge complications, and optimising the utilization and scheduling of operating rooms.
 
GMK Efficiency single-use instrumentation can facilitate time and cost savings while bringing greater reliability and predictability to multiple steps in the global delivery of TKA. GMK Efficiency comes terminally sterile and can streamline the instrumentation logistics and OR turnover for each TKA case, as all Efficiency instruments are disposed at the end of the surgery. The durability and functionality of these instruments was attained through attention to design detail and the combination of special medical grade composite technopolymers with high precision manufacturing processes. These instruments can be used as a stand alone solution or in conjunction with MyKnee 3D printed patient specific instrumentation.
 
In this modeling study by Dr Tyler Goldberg and Dr John A. Maltry is demonstrated that the majority of healthcare providers could realize substantial cost savings, improve OR utilization, and bring predictability to budgeting through less variance in the operating costs. Furthermore in this study is highlighted that, switching from reusable to Efficiency instruments, approximately 75% of simulated healthcare providers saved at least $750 per case, 50% saved at least $1,000 per case, and 25% saved over $1,200 per case. This finding suggests that single use instruments would be cost-effective in the majority of cases. GMK Efficiency instruments also dramatically reduced overtime in the OR, enabled the opportunity for an increase in the number of daily cases, and may reduce the risk of surgical site infections. Overall, this modeling study suggests that GMK Efficiency Single-use instruments have a compelling potential to help improve the quality and efficiency of delivering TKA procedures.
 
 
 

 
Read more on Becker's ASC Review

 
References:
[1] Williams, S., Wolford, M. & Bercovitz, A. Hospitalization for total knee replacement among inpatients aged 45 and over: United States, 2000–2010. NCHS data brief, no 210. Hyattsville, MD: National Center for Health Statistics. (2015).
[2] Kurtz, S., Ong, K., Lau, E. et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 2007; 89:780-785.
 

 

Medacta announces First New Zealand Surgeries utilizing the AMIS Approach

Medacta announces First New Zealand Surgeries utilizing the AMIS Approach

Tuesday, July 24, 2018 Medacta International, the privately held family-owned global leader in innovative joint replacement and spine surgery products, is proud to announce the first surgeries in New Zealand featuring a combination of the QUADRA System straight stem and the Mpact System through the revolutionary AMIS (Anterior Minimally Invasive Surgery) approach, have been performed in the last few months by Dr. Robert Elliott, M.D. at the ESC Centre, North Shore Hospital in Takapuna, Auckland.

Read more >

 

The number of surgeons adopting the Anterior Approach to hip replacement is on the rise, with an estimated 20 percent of hip surgeons now performing the procedure. Medacta, thanks to the M.O.R.E. AMIS Education Program, is leading the charge in training and supporting surgeons transitioning to this muscle-sparing technique.
 
I’m very grateful to Medacta to allow me to emulate my fellowship experience in New Zealand. Medacta’s education and technical support are crucial to success” said Dr. Robert Elliott.
 
Offered as part of the M.O.R.E. Institute, the M.O.R.E. AMIS Education Program is a comprehensive offering for surgeons seeking to become proficient in the technique, including ongoing medical education and dedicated implants and instruments.” said Francesco Siccardi, executive vice president of Medacta International. “Many surgeons across 31 countries have received training through the program. In the field, surgeons have performed more than 300,000 total hip replacements utilizing the AMIS platform so far.
 
The AMIS technique, informed by decades of clinical experience, is now a succesfully muscle-sparing approach to total hip replacement that is associated with potential positive patient outcomes such as shorter hospitalization and rehabilitation time, as well as a faster return to daily activities. Today, the AMIS technique evolved into the concept of the AMIS Experience, as it is much more than just a surgical technique, it is a complete set of services which provides for healthcare efficiency supportive of economic and commercial advantages for the hospital & surgeon.
 
Within the AMIS Experience it is possible to take advantage of:
  • SURGICAL TECHNIQUE: AMIS is an evolution of the Anterior Approach: simpler, more reproducible and less invasive
  • MEDICAL EDUCATION: The AMIS Education Program is a tested and proven method of top level continuous education which effectively helps to smooth the learning curve
  • DEDICATED IMPLANTS: Specifically developed to make their implantation easier through the Anterior Approach, sustained by clinical evidence and customer success
  • ADVANCED INSTRUMENTATION: Developed specifically to make the AMIS technique an easier and more reproducible procedure
  • TOOLS AND SERVICES: Extras provided by Medacta to further support a surgeon’s practice
 
MORE THAN 100 PUBLICATIONS AS CLINICAL EVIDENCE[1]
[1] AMIS Publication Review – M.O.R.E. Journal Supplement, April 2016. 99.98.publ rev.01
 

 

M.U.S.T. SI, Screw Fixation System for Sacroiliac Joint Fusion

M.U.S.T. SI, Screw Fixation System for Sacroiliac Joint Fusion

Medacta announced their SacroiIliac Joint fusion system was launched for sacroiliac joint surgery.
 

Read more >
Four things to know:
  1. The M.U.S.T. SI SacroiIliac Joint Screw System is designed to treat patients suffering from degenerative sacroiliitis, sacroiliac joint disruptions and degenerative sacroiliac arthritis.
  2. The system’s corresponding procedure is minimally invasive and can be optimized for the outpatient surgical setting.
  3. The system features screws coated with porous and rough hydroxyapatite, designed with hollow-body and multiple fenestrated patterned shafts to promote biological fixation.
  4. The M.U.S.T. SI SacroiIliac Joint Screw System expands on the company's current M.U.S.T. Screw System portfolio.

 

Read more about the first stateside surgeries completed in the US on Business Wire

 

GMK Sphere awarded 3A* ODEP rating

GMK Sphere awarded 3A* ODEP rating

Medacta is proud to announce that GMK Sphere was awarded the 3A* ODEP rating, confirming the excellent survival rate of the implant (latest ODEP ratings can be found at www.odep.org.uk).

Read more >

 

According to the Orthopaedic Data Evaluation Panel (ODEP) rating criteria, GMK Sphere has been evaluated in a minimum cohort of 150 knees, demonstrating Kaplan-Meier survivorship data in line with cumulative percent of revision lower than 5% at ten years. The ODEP rating is not awarded based only on a specific study (with selected surgeons), rather it comes from nationwide data of English and Welsh hospitals.
 
This excellent rating is confirmed and outmatched by the 3 years preliminary clinical outcomes of the GMK Sphere ODEP study (performed in four centers in the UK and Belgium). At three years follow-up, the implant demonstrates excellent survival with a survival rate of 99.72%. Both objective and subjective outcomes show consistent optimal values and witness the efficacy of the GMK Sphere to achieve excellent clinical results and patient satisfaction.
 

 

MySpine MC, Midline Cortical approach for pedicle screw placement

MySpine MC, Midline Cortical approach for pedicle screw placement

Medacta announced the addition of the MySpine Midline Cortical Pedicle Screw Placement Guide (MySpine MC) to its MySpine 3D printed patient specific portfolio. 

Read more >
Four things to know:
  1. MySpine MC can be used for inpatient and potential outpatient settings.
  2. It is designed to provide a muscle-sparing approach to posterior lumbar surgery. The MySpine MC technique uses low radiation dose CT-based preoperative planning with a more caudomedial entry point than traditional pedicle screw trajectories and a lower caudal-cranial angle than cortical bone trajectory.
  3. The technique is intended to avoid interference with the cranial facet joints and is designed to accommodate larger screw diameters and lengths, with four areas of cortical bone purchase for enhanced biomechanical fixation.
  4. Intraoperative utilization of 3D-printed guides for pedicle screw placement may reduce cumulative radiation exposure.

 

Read more about the first stateside surgeries completed in the US on Business Wire

 

BECKER’S ASC REVIEW - Outpatient THA: Your choice of implants can improve functional outcomes and reduce the risk of dislocation

BECKER’S ASC REVIEW - Outpatient THA: Your choice of implants can improve functional outcomes and reduce the risk of dislocation

With total hip arthroplasty, one of the main objectives is to provide a stable hip by restoring joint biomechanics. Failure to achieve this goal results in dislocation and may happen regardless of surgical approach.1 Dislocation after THA is the most common cause for revision hip surgery in the United States.2 Proper component position and soft tissue tension must be achieved during THA to reduce the risk of dislocation. Proper component position and soft tissue tension must be achieved during THA to reduce the risk of dislocation.3

Read more >
Intraoperative instability during THA can be addressed by proper restoration of femoral offset. Leg-length equality and acetabular component position are also fundamental considerations in THA for patient satisfaction and prevention of dislocation.4 Patients with spinal deformities and younger, more active patients, create higher demands on implant components needed to improve functional outcomes and avoid dislocation.
 
Femoral Offset & Leg-length Equality
Patients expectations following total hip replacement have become increasingly more demanding. Return to a pain free lifestyle with no limitations and equal leg lengths are considered the "norm"."Meeting these expectations is dependent on the approach as well as reestablishment of the patients' native biomechanics. Patients' leg length and offset should not be at the mercy of limited stem options including offset.” Said E. Stolarki, MD “The MasterLoc stem gives me incredible versatility with three offset options within an 11 mm range. Whether it is avoiding increasing native offset of a valgus DDH neck or matching the most extreme varus offset, the MasterLoc stem allows for recreating that patient's native biomechanics. This reduces trochanteric bursitis in the DDH patient and avoids increasing leg lengthening for stability in those patients with significant offset.

 

Acetabular Cup Positioning
The Mpact Double Mobility Cup has become an integral part of my hip implant armamentarium to address patients who have a high risk of dislocation.” Said R. Jain, MD, “The traditional safe zone for acetabular component inclination and anteversion, as proposed by Lewinnek, may need to be reconsidered in some patients.5 For example, patients with stiff hips, limited spinopelvic motion, have the greatest risk for dislocation. It is in these situations that I like to increase my "safe zone" by using the Mpact DM double mobility cup.” “In these patients, I find the Mpact DM cup to be invaluable. In addition, I find that the high coefficient of friction of the plasma spray coating of the Mpact cup really grabs the acetabulum when implanting, even in these osteoporotic hip fracture patients.
 

 
Read more on Becker's ASC Review

 
References:
[1] Kwon MS, et al. Does surgical approach affect total hip arthroplasty dislocation rates? Clin Orthop Relat Res. 2006;447:34–38.
[2] Gwam CU, et al. Current epidemiology of revision total hip arthroplasty in the United States: National Inpatient Sample 2009 to 2013. J Arthroplasty 2017;32:2088e92. https://doi.org/10.1016/j.arth.2017.02.046.
[3] Forde B., et al. Restoring femoral offset is the most important technical factor in preventing total hip arthroplasty dislocation. Journal of Orthopaedics 15 (2018) 131-133 
[4] M.M. Innmann et al. Additive influence of hip offset and leg length reconstruction on postoperative improvement in clinical outcome after total hip arthroplasty. The Journal of Arthroplasty 33 (2018) 156-161 
[5] Lewinnek GE, et al. Dislocations after total hipreplacement arthroplasties. J Bone Joint Surg Am 1978;60:217-20.

 

300,000 AMIS PROCEDURES WORLDWIDE!

300,000 AMIS PROCEDURES WORLDWIDE!

We are proud to announce that in May 2018 we reached the significant milestone of 300,000 AMIS PROCEDURES WORLDWIDE!

Read more >

 

AMIS (Anterior Minimally Invasive Surgery) is a hip replacement technique that follows both an intermuscular and internervous path to greatly decrease damage to periarticular structures while preserving tissue and which is supported by the industry’s most detailed surgeon training protocol. 
 
The promotion of patient well-being through AMIS is a cornerstone of Medacta’s mission, as it exemplifies our belief that only with a strong focus on medical education can surgical innovation truly move the industry forward,” said Francesco Siccardi, Executive Vice President of Medacta International. “The patient-centric technique is also ideal for the outpatient or same-day surgery settings, providing more options for both surgeons and patients in today’s changing healthcare landscape.
 
Today, the AMIS technique evolved into the concept of the AMIS Experience, as it is much more than just a surgical technique, it is a complete set of services which provides for healthcare efficiency supportive of economic and commercial advantages for the hospital & surgeon.
 
Within the AMIS Experience it is possible to take advantage of:
 
SURGICAL TECHNIQUE: AMIS is an evolution of the anterior approach: simpler, more reproducible and less invasive.
 
MEDICAL EDUCATION: The M.O.R.E. AMIS Education Program is a tested and proven method of top level continuous education which effectively helps to smooth the learning curve.
 
DEDICATED IMPLANTS: Specifically developed to make their implantation easier through the anterior approach, supported by clinical evidence and customer success
  • AMIStem-H and QUADRA-H have been awarded the 7A rating by the ODEP Panel
  • AMIStem-H: 98.9% survival rate (Kaplan-Meier method) including any reason for revision as endpoint, at minimum 5 years follow-up[1] 
  • QUADRA-H: ONLY 1 revision for aseptic loosening out of 283 cases (survival rate of 99.65% with aseptic loosening as endpoint), at a minimum follow-up of 10 years[2]
  • Versafitcup CC Trio: 98.6% survival rate including any reason for revision as endpoint, at minimum 10 years follow-up[2]
ADVANCED INSTRUMENTATION: Developed specifically to make the AMIS technique an easier and more reproducible procedure.
 
TOOLS AND SERVICES: Extras provided by Medacta to further support a surgeon’s practice.
 
 
MORE THAN 100 PUBLICATIONS AS CLINICAL EVIDENCE[3]

 
[1] Kalberer F, Krupp F, Molnar V, Schmied-Steinbach A, Schläppi M. AMIStem-H: Radiological results at 5 years. M.O.R.E. Journal Supplement, July 2016
[2] Rahm S, Tondelli T, Steinmetz S, Schenk P, Dora C, Zingg P. Versafit Cup and Quadra Stem in THA Through the Direct Anterior Approach: Analysis of a Consecutive Series of 283 Hips with a Minimum Follow-up of 10 years. Podium presentation at the 78th Annual Congress of the Swiss Orthopaedics Jahreskongress, Montreux, Switzerland, June 6-8, 2018
[3] AMIS Publication Review – M.O.R.E. Journal Supplement, April 2016. 99.98.publ rev.01

 

BUSINESS WIRE: Geisinger Announces It Will Stand Behind Cost of Hip Surgery for a Lifetime.

BUSINESS WIRE: Geisinger Announces It Will Stand Behind Cost of Hip Surgery for a Lifetime.

Collaboration with Medacta believed to be the first of its kind in the industry.

Read more >

Geisinger collaborated with Medacta International on a first-of-its-kind pilot program to provide a Geisinger Health Plan member who was receiving hip-replacement surgery an unlimited time frame for future surgical care and cost that may be needed. These costs will be proportionally shared between Geisinger and Medacta, including the device itself and all hospital costs, while the patient remains with Geisinger Health Plan and is treated by Geisinger providers.

“Surgeon education and mentorship is a core pillar of Medacta’s mission, with hundreds of surgeons from around the world receiving training each year through our renowned M.O.R.E. Institute and AMIS Education Program,” said Francesco Siccardi, Executive Vice President of Medacta International. “This value-based care partnership with Geisinger, our first, further underscores Medacta’s commitment to improving the patient experience while redefining the orthopaedic ‘product’ to encompass not only the implant, but also accompanying surgical technique, education and instrumentation. We are proud to go beyond implant replacement and share in the risk and overall cost of patient care, which we believe to be an unprecedented step for an orthopaedic manufacturer.

 
Read more on BusinessWire
BECKER’S ASC REVIEW: Medacta moves into partial knees with the MOTO medial partial knee

BECKER’S ASC REVIEW: Medacta moves into partial knees with the MOTO medial partial knee

Partial knee replacements are rapidly becoming a common choice for orthopedic surgeons seeking to offer patients the option of pain relief in the ASC setting. With patient expectations increasing, the MOTO™ Partial Knee System has been designed to simplify the challenges of gap balancing and alignment — truly taking the potential of a partial knee procedure to the next level.

Read more >

 

J. Mandume Kerina, MD, of Leesburg (Fla.) Regional Medical Center, has performed hundreds of mobile and fixed bearing partial knees, taught countless surgeons in both techniques as a surgeon educator and lately has led a team of experts in detailing the road map for the next generation of UKA, the MOTO Partial Knee System. Both mobile and fixed bearing implants have been highly successful, yet each has room for improvement. The team’s mission was simple: make today’s unicompartmental knee arthroplasty that serves all patients, from elderly to high-demand, in all sizes ranging from the petite to the professional athlete, and is well suited for today’s ASCs with efficient trays and no requirement for expensive robotic technologies.

So, why MOTO? Aside from implant design, instruments and education are key components.

The design rationale required a compartment-specific approach. The MOTO implants are designed for each specific compartment using an anthropometric database of thousands of knee CT scans to optimize anatomic coverage, contours, size range and precise fit. MOTO is a cemented fixedbearing UKA, using proven materials.

The Co-Cr-Mo femoral component comes in 10 sizes; the titanium alloy (Ti-Al6-V4) tibial tray comes in eight sizes, and the high-quality polyethylene insert in single-millimeter incremental thicknesses. It is a round-on-flat design that minimizes shear stress on the implants, and allows for all femoraltibial size combinations. The femoral component is anatomic, with anatomic posterior femoral condyle coverage for deep flexion. It has cement interdigitation recesses, and two pegs which diverge from the posterior flange for secure fixation (three pegs on largest sizes). Likewise, the tibial tray has the cement interdigitation recesses, two pegs and a keel.

Perhaps the most distinguishing feature of MOTO is the instrumentation that allows for precise bone resections to balance knee flexion-extension gap mismatch, while maintaining slight alignment under-correction. UKA is unique in that the implants must be placed within a given soft tissue envelope specific to that knee, without ligament releases, and still achieve balance and alignment goals. This requires precise (1 mm) bone resections on the tibia, distal femur and posterior femoral condyle. MOTO enables the surgeon to independently adjust flexion and extension gaps, and allows the surgeon to change any step all the way up to cementation. Even the medial-lateral positioning of the femoral component can be changed after trial reduction to optimize positioning. All femoral components have the same two lug holes, distal and posterior cuts, enabling a change in femoral component sizing even after the cuts and lug drill holes were made.

The Medacta commitment to surgeon education is a key component to the success of MOTO. Surgeons benefit from one-on-one instruction and proctoring as well as visiting design surgeons and attending learning centers for didactics and cadaver lab training.

Read more on Becker's ASC Review

 

 

Medacta Japan Highlights Success of 2nd Japanese M.O.R.E. Symposium

Medacta Japan Highlights Success of 2nd Japanese M.O.R.E. Symposium

Medacta Japan announced the success of its 2nd Japanese M.O.R.E. Symposium, held on September 30 to October 1, 2017 and attended by over 300 medical professionals, with presentations from over 40 international surgeons. patients’ wellbeing.

Read more >

 

Reflecting Medacta’s ongoing commitment to continuous medical education, the event focused on how implant design, techniques and patient-specific treatment can improve outcomes and patient satisfaction in the changing orthopaedic landscape, positively impacting the sustainability of the healthcare system. More than 40 Japanese orthopaedic surgery experts presented at the meeting, covering topics on innovation, education and healthcare sustainability, with important contributions from international experts who traveled from Australia, Europe and the United States to attend the event.
 
Surgical education and training has been a pillar of Medacta’s mission and identity since the company began. We believe it is the foundation for optimal clinical outcomes and both patient and surgeon satisfaction,” said Francesco Siccardi, Executive Vice President of Medacta International. “The success and the incredible growth of Medacta Japan, in both joint and spine, is a further confirmation of that belief. We’re honored that a growing number of surgeons depend on us as a reliable partner, and we will do our best to maintain our vision for a bright future in Japan.
 
For more information about the 2nd Japanese M.O.R.E. Symposium and Medacta, including scientific sessions, visit: 2more-jpn.medacta.com.
 
Read more on BusinessWire

 

 

Medacta International ranked 1st in the BrandNew@DKOU contest with the Efficiency KneePack!

Medacta International ranked 1st in the BrandNew@DKOU contest with the Efficiency KneePack!

Medacta International participated with 16 other companies to the contest during the German Congress of Orthopedic and Trauma Surgery (DKOU), the second largest European orthopaedic congress, and experts and surgeons who attended the event were asked to vote for the most innovative orthopaedic product of 2017.

Read more >
 

BERLIN 27th October 2017 – Medacta is proud to announce that the Efficiency KneePack, the Ultimate Solution for Total Knee Replacement (TKR), ranked 1st in the BrandNew@DKOU contest!

 

Delivered just in time for the surgery, terminally sterile and in a single lightweight box, Efficiency KneePack includes GMK Sphere medially stabilised total knee implant, MyKnee patient matched technology and GMK Efficiency single use instrumentation. Based on an advanced pre-operative planning, the hospital receives all and only the instruments and implants needed for the surgery. Everything is ready for use, streamlining instruments management and shortening the OR time. This complete solution can help to improve hospitals and clinics TKR workflow, reducing the resources needed to manage the process and enabling an even stronger focus on the patient. 
 
After the excellent feedbacks and results at Hirslanden Clinique La Colline (Geneva, CH), the first to trial this advanced solution, Medacta is ready to make this the new gold standard for TKR management in more centres. 
Medacta would like to thank all the participants who voted for this new complete solution for TKR” said Francesco Siccardi, Executive Vice President of Medacta International, “this award is a great recognition of Medacta's efforts to provide patients and surgeons around the world with innovative solutions and cutting edge technologies to improve their satisfaction as well as healthcare systems sustainability”.
 
 

 

Medacta Announces First U.S. Surgery Utilizing New Medacta Shoulder System

Medacta Announces First U.S. Surgery Utilizing New Medacta Shoulder System

Medacta is excited to announce  the completion of the first surgery in the United States utilizing its Medacta Shoulder System, performed by Matthew D. Saltzman, M.D., Associate Professor of Orthopaedic Surgery at the Northwestern Memorial Hospital in Chicago, Illinois. 

Read more >
 

Medacta’s expansion into the shoulder arthroplasty market continues with the receipt of FDA clearance for the Reverse Shoulder prosthesis. Additionally, the first surgery in the United States utilizing the Medacta Shoulder System was performed by Matthew D. Saltzman, M.D., Associate Professor of Orthopaedic Surgery at the Northwestern Memorial Hospital in Chicago, Illinois.

The procedure went very well,” said Dr. Saltzman, who specializes in shoulder and elbow surgeries and has been practicing orthopedics for fourteen years. “The Medacta Shoulder System’s instrumentation and implants allow for impressive anatomic restoration, resulting in an efficient surgery and, hopefully, improved patient outcomes.”

The Medacta Shoulder System, is a modular solution that features a broad range of options, including wide-ranging sizes, adjustable offset, and innovative configurations. Developed by a group of experts from the United States, Europe, and Australia, the technology offers the flexibility to move from a hemi-arthroplasty to a total or reverse arthroplasty thanks to its modularity.

The Shoulder System is also supported by the Medacta Orthopaedic Research and Education (M.O.R.E.) Institute’s Clinical Excellence Program, and is part of a multi-center, post-marketing, prospective, open clinical study that will collect clinical and radiological outcomes for the next ten years. “The new Medacta Shoulder System is a continuation of our effort to improve orthopedic implant design and configurability for the benefit of both surgeons and their patients,” said Francesco Siccardi, Executive Vice President of Medacta International. “This latest surgery in the United States marks a milestone for Medacta in line with our company’s patient-centric vision and the same ambition that has helped us become a leader in knee, hip, and spine technology.

Medacta will launch the Shoulder System for the U.S. market at the American Academy of Orthopaedic Surgeons Annual Meeting, which will be held in New Orleans in March 2018. For more information about Medacta, please visit medacta.com or follow @medacta on Twitter.

 
 

 

BECKER’S SPINE REVIEW: 20 total joint replacements in 3 days: How a pair of hurricanes wasn't enough to stop a One World Surgery Mission from serving Honduran patients in need, by Laura Dyrda

BECKER’S SPINE REVIEW: 20 total joint replacements in 3 days: How a pair of hurricanes wasn't enough to stop a One World Surgery Mission from serving Honduran patients in need, by Laura Dyrda

Hundreds of physicians and medical care providers embark on medical mission trips each year to care for underserved populations across the globe. However, few trips have been as ambitious and logistically-challenging as the recent mission trip to Honduras sponsored by One World Surgery. In the short time between hurricanes Harvey and Irma, a group of twenty-two healthcare professionals completed twenty total joint surgeries. Medacta donated the prostheses needed to complete the twenty surgeries through the Medacta for Life Foundation.

Read more >

 

One World Surgery, in partnership with Surgical Care Affiliates and Medacta, recently supported twenty-two medical professionals as they traveled to Holy Family Surgery Center in Honduras on a medical mission trip. This surgery center is a nonprofit facility that provides free care to the local community.

The medical mission team was led by Tyler Goldberg, MD (Texas Orthopedics, Sports & Rehabilitation Associates, Austin, TX) and Thomas McCoy, MD (OrthoCarolina, Charlotte, NC). Both surgeons opted to bring their surgical staff to ensure safe and efficient procedures. "Coordination is key when performing a short-term mission trip," said Dr. Goldberg. "Preparation began months in advance to organize the team, select patients and finally prepare instruments and implants to ensure surgical success. No one person can do this alone. The SCA and One World Surgery teams were vital to this process."
 
The team performed fifteen total knee replacements utilizing the GMK® Efficiency Single Use Instruments and five total hip replacements featuring Medacta’s AMIS® platform. Medacta, through its "Medacta for Life Foundation", was honored to provide the twenty joints and surgical instrumentation needed for these cases.

The Medacta for Life Foundation is proud to support One World Surgery’s mission by providing the tools to help deserving patients in disadvantaged countries," said Francesco Siccardi, Executive Vice President of Medacta International. "It is extremely gratifying to know that our donation enabled 20 total joint patients to regain mobility thanks to the capable hands of our surgeon volunteers in Honduras. Our GMK Efficiency line of pre-sterilized and single-use surgical orthopedic instruments is ideal for use in hospitals with limited resources and allows us to participate in these meaningful causes."
 

Read more on Becker's Spine Review

 

 

Dr. John Masonis to perform live anterior hip procedure featuring the MiniMAX Hip System at 6th Annual ICJR Anterior Hip Course

Dr. John Masonis to perform live anterior hip procedure featuring the MiniMAX Hip System at 6th Annual ICJR Anterior Hip Course

Thursday, October 19 @ 1:05pm ET. Medacta is supporting a live anterior total hip surgery webcast at the 6th Annual ICJR Anterior Hip Course in Houston, Texas. Dr. John Masonis from OrthoCarolina in Charlotte, NC will perform the surgery utilizing Medacta’s AMIS (Anterior Minimally Invasive Surgery) platform. Dr. Tyler Goldberg from Austin, TX will moderate.

Read more >
 
Visit http://icjr.net/livesurgery/masonis to view the live webcast at 1:05 PM Eastern on Thursday October 19, 2017. The webcast will be archived on the ICJR website and APP within 60 days after the event.
 
Dr. Masonis will be introducing the MiniMAXTM Hip System to the U.S market during the procedure. The MiniMAXTM System furthers Medacta’s commitment to minimally invasive products with a reduced length femoral component with design enhancements to maximize metaphyseal fit and fill, while also providing increased offset and version for added stability.
 
Please note that the link above will not be live until the day of the webcast.
 
 
 

 

 

ARCHIVES OF BONE AND JOINT SURGERY: Restoration of the Mechanical Axis in Total Knee Arthroplasty Using Patient-Matched Technology Cutting Blocks. A Retrospective Study of 132 Cases.

ARCHIVES OF BONE AND JOINT SURGERY: Restoration of the Mechanical Axis in Total Knee Arthroplasty Using Patient-Matched Technology Cutting Blocks. A Retrospective Study of 132 Cases.

MyKnee Patient Matched Technology has proven to allow precise preoperative planning, correct alignment, excellent implant size matching, less instrumentation trays needed, reduced surgical step and surgical time resulting in improved O.R. efficiency. This study by Dr. Greenhow and Dr. Loucks provides additional evidence in terms of coronal plane alignment and prediction of component size.

Read more >

 
A 2016 study published in the Archives of Bone and Joint Surgery evaluates the accuracy of bone cuts and the resultant alignment using the MyKnee patient specific cutting blocks.
 
The authors retrospectively reviewed 132 patients undergoing primary TKR for osteoarthritis by one single surgeon. The operative time, the preoperative HKA axis based on the CT-scan, the postoperative HKA axis based on long axis standing x-rays, the planned and the actual size of the femoral/tibial components and the number of the intraoperative recuts were measured.
 
The average preoperative HKA axis was 177.5 (range 163.5 to 194.0), whereas the average postoperative HKA axis was 179.4 (range 177.1 to 182.7). No outliers were reported in the study. Intraoperatively, 4 femoral components (3.03%) and 7 tibial components (5.30%) applied to the patients were different than the planned size. There was no need of recuts intraoperatively.
 
The MyKnee system evaluated in the study was shown to be remarkable reliable in the coronal plane alignment and the prediction of the component size. 
 
Read more on ABJS.
 
 
 

 

 

Value in Single Use Instruments for Total Knee Arthroplasty: Patient Outcomes and Operating Room Efficiency

Value in Single Use Instruments for Total Knee Arthroplasty: Patient Outcomes and Operating Room Efficiency

Healthcare system is moving towards a value-based model to increase the quality of patient outcomes while simultaneously reducing cost. Total Knee Arthroplasty (TKA) has been shown to be one of the most clinically and cost effective procedures in orthopedics. Tyler Goldberg, MD, of Austin-based Texas Orthopedics, Sports & Rehabilitation Associates et Al. have just completed this study that analyzes the potential benefits of GMK Efficiency single use instrumentation compared to conventional instruments in TKA.

Read more >

Due to a significant growth in TKA procedures providers continually evaluate new ways to perform these procedures while maintaining high quality outcomes at reduced cost. GMK Efficiency Single Use Instruments were developed to accomplish both these goals.
 
Efficiency instruments have been used in over 5000 TKA worldwide, during its Limited Market Release phase in accordance with the M.O.R.E Excellence Clinical Program, dramatically reducing the need and reliance on traditional metal instrumentation. Efficiency instruments also offer the potential benefits of reduced risk of infection, increased operating room productivity, significant savings resulting from volume reductions in instrument tray processing and sterilization, and costs associated with loaner instrumentation. 
 
In total, the economic model developed in this paper establishes a realizable benefit of $1,198 per procedure when using Efficiency instruments.
 
Read more on GMK Efficiency.
 
 
 

 

 

4. HIP & KNEE INTERNATIONAL SYMPOSIUM - Press release

4. HIP & KNEE INTERNATIONAL SYMPOSIUM - Press release

Lienz - 15 - 16 September 2017 An interactive exchange regarding the AMIS method, the MyKnee system, complications and revision surgeries for GMK Sphere users, Periprothetic infections and complex case presentations.

Read more >
 
Symposium around knee and hip in Lienz
4. International meeting on innovative endoprosthetics at the regional hospital.
Chronik · 17. September 2017 · Redaktion
 
"Endoprostheses are implants that remain permanently in the body and completely or partially replace the damaged body parts. The most famous are probably the artificial hip joints.“ Thus Wikipedia describes endoprosthetics, a medical specialty (field) in which the orthopaedic specialists (surgeons) of the regional hospital BKH Lienz enjoy a very good reputation. The specialised centre for orthopaedics, the BKH Lienz, is a reference centre and also a training area for innovative knee and hip endoprosthetics. This was the topic of the fourth meeting of international orthopaedists in Lienz, which was prepared and organised by Doctors Herbert Strobl and Valjdet Saciri, who have welcomed approximately 70 colleagues in the Dolomites. The organisers of the meeting with guests from Switzerland. From left: Prof. Niklaus Friederich (Basel), Dr. Samuel Blatter (Winterthur), Dr. Neither Helmy (Solothurn), Dr. Herbert Strobl and Dr. Valjdet Saciri. Among the speakers were some important names in the field of orthopaedics, specialists (surgeons) from clinics in Berlin, Lausanne, Zurich, Vienna and Paris. The first day, lectures and discussions, were dedicated to the hip joint, with the second day dedicated to the knee. The two organisers also joined the meeting as speakers. Dr. Herbert Strobl talked about his twelve years of experience with minimally invasive hip surgery and how more than a thousand patients have been successfully operated on using this method in Lienz. Dr. Valjdet Saciri presented the specialised institutions with new models of knee prostheses that have been used in Lienz for three years.
 

Kleine Zeitung

Orthopaedic experts meet in East Tyrol
The fourth International Symposium on innovative hip and knee endoprosthetics will take place in Lienz. Experts from all over the world will discuss the innovations and complications.
By Karina Hartweger | 12.00 Uhr, 16. September 2017
 
Today, 70 doctors from all over the world will be in Lienz to discuss minimally invasive hip surgery and knee replacement surgery. The meeting was organised by Dr. Herbert Strobl and Dr. Valjdet Saciti from the Orthopaedic Centre in Lienz. Also, Manfred Kuschnig will be present, the Medical Director of the Department of Orthopaedics at the Elisabethinen-Krankenhaus Klagenfurt hospital. Both hospitals are regarded as reference centres for this surgical technique, also called the AMIS method (Anterior Minimally Invasive Surgery).  "The exchange of experience is indispensable in terms of quality assurance. We all learn from mistakes", says Dr. Strobl. For Dr. Kuschnig there is much to underline: "The patients are changing, they are younger, born in the 1960s. Reasons are habits, diet, and also that the tissue does not get better over the years."

Skin Incision
It is also important to point out to the surgeons that the AMIS method is not designed to have a particularly small cut, but the procedure is carried out in such a way that the patient returns as soon as possible to their daily routine. "This means that muscles, tendons and ligaments are not damaged," explains Dr. Strobl. Between 500 and 600 surgical operations are performed annually in Lienz Orthopaedics, of which 150 are hip and 100 knee prosthesis surgeries. "The number of knee prostheses has risen in recent years, as technology has evolved and the patient has become less hostile than before", says Dr. Saciri.
 
 
Lectures of internationally recognised orthopaedic experts at the BKH Lienz hospital.
In the middle of September 2017, the district hospital in Lienz was the site of a high-calibre medical congress.
More than 70 orthopaedists and surgeons exchanged opinions on technical innovations and latest innovative findings in the field of hip and knee endoprosthetics. The scientific leaders and organisers of the 4th International Hip and Knee Symposium, OA Dr. Valjdet Saciri and FA Dr. Herbert Strobl, were able to involve internationally renowned luminaries for lectures, Dr. Frederic Laude, Prof. Dr. Olivier Borens and Prof. Dr. F. Niklaus Friedrich.
 
The heads of the specialist centre for orthopaedics and orthopaedic surgery at BKH Lienz, FA Dr. Herbert Strobl and OA Dr. Valjdet Saciri, "The event was a complete success, confirmed by positive feedback reports," says FA Dr. Herbert Strobl. Together with OA Dr. Valjdet Saciri, he is responsible for the orthopaedics and orthopaedic surgery centre, which was installed at BKH Lienz in 2003. In the meantime, the facility has developed into a renowned reference and training centre for the minimally invasive surgery of hip and knee endoprostheses. “Here in Lienz we treat and operate at an international level and are not affected by any major medical centres," says OA Dr. Saciri on the high quality of the treatment offer in Osttirol's largest medical facility. Knee and hip problems, according to the two surgeons, are no longer only for the elderly. "While the artificial joint replacement used to be associated with long rehabilitation times, minimally invasive surgical techniques now ensure very patient-friendly methods. The results are impressive. A large percentage of patients can already be mobilised on the first post-operative day."
What kind of advantages the modern hip replacement can have on the hip joint? "Since 2005, we have been using the AMIS technology at BKH Lienz. The access path to the diseased hip joint is made through a small skin incision, so the muscles and tendons are protected. This method of implanting a hip endoprosthesis has become a common, tried and tested method that has proved to be very safe and effective. Today hip replacement surgery is one of the most successful surgical operations used in trauma cases. The patients who suffer from an osteoarthritis demonstrated significant pain reduction, a significantly improved quality of life and a large increase in mobility both short and long term", explains FA Dr. Herbert Strobl.
The development does not stop, the techniques always grow faster and better and also the materials are becoming ever more durable”, is one of the core statements of the Dr. Frederic Laude from the Clinique Paris said to the surgeons at Lienz. Dr. Laude has carried out pioneering work and has developed hip surgery from the front according to the AMIS method. From the discussions with him and the other symposium participants Dr. Strobl and Dr. Saciri also gain the insight that much more worldwide periprosthetic infections occur during joint replacement than previously. "The good news for the patients is that today, with this infection, but with an optimal diagnosis / therapy concept and with the necessary patience, we can ensure treatment success rates of over 90 percent," Valjdet Saciri notes." Various methods of periprosthetic infections therapy were presented to us by one of the experts in this field, Prof. Dr. Olivier Borens of the Swiss Center Hospitalier Universitaire Vaudois. "In this context it’s interesting to note that smaller hospitals clearly have the advantage in respect of the large hospitals regarding the contamination of germs."This is clearly demonstrated by scientific studies!"
 
The second focus of the symposium in Lienz was on knee endoprosthetics. Here the experts confirmed the success of the implantation "MyKnee" method. "Prior to the operation, CT or MRI images from the radiological examination of the knee are used to produce an individual 3D model. On the basis of this important preliminary work, it is possible to proceed with the implantation in such a way that substantially better results regarding the mobility and also the longevity of the endoprosthesis are achieved.
The prosthesis is fixed into the bone in a better way during the surgery and remains in its optimal position", says OA Dr. Saciri. "It is important to remember that the knee is a very complicated joint with a special biomechanics. In contrast to other joints, such as the hip, it does not have a strong surrounding muscular mantle. It is exposed to great mechanical loads as a weight-bearing joint and is therefore very vulnerable to injury." “Medical research in knee endoprosthetics" - concludes OA Dr. Saciri - "is going in the direction of avoiding cartilage in order to avoid damage to cartilage without therapies. Prof. Dr. F. Niklaus Friedrich of the University Hospital in Basel, a well-known expert in this field, has taught us in his lecture that digital surgical techniques will play an increasingly important role in the future."
 
 
ORTHOPEDICS THIS WEEK: Medacta: 250th AMIS Learning Center on Anterior Hip Approach, by Elizabeth Hofheinz

ORTHOPEDICS THIS WEEK: Medacta: 250th AMIS Learning Center on Anterior Hip Approach, by Elizabeth Hofheinz

Medacta International, based in Castel San Pietro, Switzerland, is known for its training and support of surgeons. Now, the company and the Medacta Orthopaedic Research and Education (M.O.R.E.) Institute have announced the 250the M.O.R.E. AMIS (Anterior Minimally Invasive Surgery Learning Center). The event, to be held September 15-16, 2017 in Chicago, Illinois, will be followed by a European event on September 25-26, 2017 in Basel, Switzerland.

Read more >

“The promotion of patient well-being through AMIS is a cornerstone of Medacta’s mission, as it exemplifies our belief that only with a strong focus on medical education can surgical innovation truly move the industry forward,” said Francesco Siccardi, executive vice president of Medacta International. “The patient-centric technique is also ideal for the outpatient or same-day surgery setting, providing more options for both surgeons and patients in today’s changing healthcare landscape.”

Read more on Orthopedics This Week

 
ORTHOPEDICS THIS WEEK: Education as a Competitive Weapon, by Robin Young

ORTHOPEDICS THIS WEEK: Education as a Competitive Weapon, by Robin Young

In this week’s publication of “Orthopedics This Week”, Medacta’s AMIS education program was featured describing it as “an extraordinarily effective program which rises to the status of education to competitive tool.” The article discusses Medacta's innovative education process, highlights the learning experience of Ronald W. Singer MD, of OrthoCarolina in Charlotte, NC, and details the benefits of the anterior procedure verses the posterior technique.

Read more >

Read more on Orthopedics This Week

 
BECKER’S SPINE REVIEW: How single-use instruments facilitate jump from inpatient to outpatient total knee arthroplasty, by Megan Wood

BECKER’S SPINE REVIEW: How single-use instruments facilitate jump from inpatient to outpatient total knee arthroplasty, by Megan Wood

Save time, limit processing costs and enhance procedure accuracy: these are the key points when referring to the growing number of TKR procedures. Medacta's innovative technologies respond to the needs of the surgeon through the conjunction of MyKnee patient matched technology and GMK Efficiency single use instrumentation to implant the GMK Sphere knee.

Read more >

 

A 2016 study published in the Journal of Bone and Joint Surgery predicts total knee arthroplasties will witness a 673 percent boost by 2030.
Driven by such a significant projected boost of total knee procedures, surgeons are seeking innovative technology and techniques to save time, limit processing costs and enhance accuracy when performing these procedures as they transition to same-day surgery and outpatient settings.
 
Tyler Goldberg, MD, of Austin-based Texas Orthopedics, Sports & Rehabilitation Associates, and Coleman Fowble, MD, of Columbia, S.C.-based Midlands Orthopaedics & Neurosurgery, specifically prefer TKA technology adaptable to the outpatient setting and decided to leverage Medacta's MyKnee Patient Specific Instrumentation in conjunction with GMK Efficiency single-use instrumentation.
 
When used with Medacta's GMK Efficiency single-use instruments, Medacta's MyKnee patient-matched cutting block technology facilitates implantation of the Medacta GMK Sphere Total Knee Implant System during outpatient or same-day surgical procedures. The combination of these single-use instrument platforms has successfully reduced operative setup and breakdown times, instrument processing costs and time, storage space and weight. Terminally sterile, the platforms also reduce the need for a bulky sterilization unit on the premises.
 
Tyler Goldberg, MD: “We recently looked at 100 cases using the MyKnee Efficiency technique versus traditional technique utilizing a Sphere implant.[…] Our economic modeling projected a $1,189.10 per case savings when using the MyKnee Efficiency products. We further found a 25 minute per case improvement in case time. Additionally, the Efficiency instruments come pre-sterilized so the CSD is eliminated, which accounted for $700 per case considering the time and number of trays processed.
 
Coleman Fowble, MD: “What you're doing is eliminating a lot of the costs of sterilization, and not only from the physical cost of sterilization but the labor costs of getting trays ready; the time component of money and physical cost of sterilization as well. Additionally, there is no cost for storage of the equipment.
 

Read more on Becker's Spine Review

 

 

MySpine: a proven technology to help in pedicle screws placement critical steps

MySpine: a proven technology to help in pedicle screws placement critical steps

The MySpine technology, along with the M.U.S.T. screw system, leads to a more accurate screw positioning for both junior and expert surgeons as reported in the study “Accuracy of patient-specific template-guided vs. free-hand fluoroscopically controlled pedicle screw placement in the thoracic and lumbar spine: a randomized cadaveric study” by Dr. Farshad et. al. (Eur Spine J. 2016).

Read more >
Medacta is proud to announce that the MySpine Pedicle Screw Placement System, awarded at NASS as best new technology in Spine for its ability to reduce radiation in the OR, decrease operating room time and improve screw placement accuracy, has been used to implant over 3’000 M.U.S.T. Pedicle Screws.
 
MySpine is a tailor made patient specific spine instrument, created to lead the surgeon through the critical steps of accurate pedicle screw placement whilst reducing the surgical time and intra-operative X-ray radiation.
 
The MySpine technology, along with the M.U.S.T. screw system, leads to a more accurate screw positioning for both junior and expert surgeons as reported in the study “Accuracy of patient-specific template-guided vs. free-hand fluoroscopically controlled pedicle screw placement in the thoracic and lumbar spine: a randomized cadaveric study” by Dr. Farshad et. al. (Eur Spine J. 2016).
 
In this study, worthy results in terms of screw positioning mean time have been achieved with the MySpine technique; the overall time is reduced by about 30% vs the free hand technique.
 
The dedicated MySpine Low Dose CT protocol minimizes the X-ray exposure for the patient (more than 30 times less irradiation than using C-Arm or O-Arm technologies), moreover MySpine pedicle screw placement potentially allows for a complete reduction of intraoperative fluoroscopy without sacrificing accuracy (as reported by Dr. Farshad; up to 50 full spine X-rays less than free-ha technique).
 
Thanks to an online portal with interactive 3d planning, the surgeon determines the entry points for the pedicle screws and sets their trajectory along with the main geometrical parameters.
 
MySpine cases are managed entirely online with no need to install additional software. The case database is available to the surgeon at any time, from anywhere and the information on the website is always kept  up-to-date.
 
MySpine system comprehends Standard guides, suitable for challenging deformities and long constructs, along with Low Profile guides, ideal for lower lumbar regions and degenerative cases.
 
 
MySpine guides are positioned on the vertebra using dedicated contact areas, such as the lamina, spinous and transverse processes, in order to achieve the maximum stability.
MySpine guides are designed to preserve the patient’s anatomy.
Distal windows enhance the field of view during all surgical steps.
 
 
Both standard and low profile guides are now available in Australia, EMEA, Japan, and US.
 
Please visit our new website to find all the supporting material.
 
Read more on MySpine.
 
 

 

 

New Medacta Website

New Medacta Website

Medacta is delighted to officially announce that our new and refreshed website is now online! The updated site includes changes to navigation, optimisation for mobile devices and also an improvement to the content structure. The goal of this new website is to provide our visitors with easier access to information regarding Medacta’s products, services and solutions.

Read more >
Medacta is delighted to officially announce that our new and refreshed website is now online!
 
Please take a look at  medacta.com
 
The updated site includes changes to navigation, optimisation for mobile devices and also an improvement to the content structure.
The goal of this new website is to provide our visitors with easier access to information regarding Medacta’s products, services and solutions.
 
All the sections have been completely re-designed to offer an enhanced user experience. 
Amongst the new features, the ‘Surgeon Locator’ is more user-friendly and based on geographical location to make sure that Surgeons can be easily reached by their Patients.
 
Keep up to date by visiting the ‘News’ section which constantly features new helpful information, articles, newsletters, company announcements and much more. 
Medacta hopes you find the new website refreshing and easy to navigate. 
Hoping to welcome you soon to medacta.com
 
Follow @Medacta on Twitter.
 
 
 

 

 

BECKER’S SPINE REVIEW: Why the direct anterior approach for THA is the future, by Megan Wood

BECKER’S SPINE REVIEW: Why the direct anterior approach for THA is the future, by Megan Wood

Orthopedic surgeons consider several factors before performing outpatient total hip replacement, including which approach to use. Thomas Ellis, MD, of Columbus, Ohio-based Orthopedic One; Coleman Fowble, MD, of Columbia, S.C.-based Midlands Orthopaedics & Neurosurgery; and John Masonis, MD, of Charlotte, N.C.-based of OrthoCarolina, discuss why they adopted the direct anterior approach for THA and the benefits they've seen.

Read more >

 

Season's greetings

Season's greetings

Wishing you a joyful Holiday Season and a prosperous New Year!

Read more >

Wishing you a joyful Holiday Season and a prosperous New Year!

MEDICAL DESIGN & OUTSOURCING: Medacta launches new hip implant and celebrates 20,000 GMK Sphere Knee implants, By Abigail Esposito

MEDICAL DESIGN & OUTSOURCING: Medacta launches new hip implant and celebrates 20,000 GMK Sphere Knee implants, By Abigail Esposito

Medacta International, the privately held family-owned global designer of innovative joint replacement and spine surgery products, showcased its new MasterLoc Hip System and GMK Sphere Knee at the 26th American Association of Hip and Knee Surgeons (AAHKS) Annual Meeting, held from November 10 to 13, 2016 in Dallas, Texas.

Read more >
BECKER’S SPINE REVIEW: 3 things to know about Medacta's new hip and knee joint replacement systems, by Eric Oliver

BECKER’S SPINE REVIEW: 3 things to know about Medacta's new hip and knee joint replacement systems, by Eric Oliver

Castel San Pietro, Switzerland-based Medacta showcased its new MasterLoc Hip System and GMK Sphere Knee at the 26th American Association of Hip and Knee Surgeons Annual Meeting. Here's what you need to know.

Read more >

 

BECKER’S ASC REVIEW: Outpatient anterior hip replacement surgery: The future is here, by Laura Dyrda

BECKER’S ASC REVIEW: Outpatient anterior hip replacement surgery: The future is here, by Laura Dyrda

There are more high-acuity orthopedic procedures going to the outpatient setting today, including total joint replacements. Orthopedic technology is developing for minimally invasive procedures, and new pain management protocol and post-surgical care allow patients to leave the outpatient centers within 23 hours after surgery. "It's been a natural progression over many years where we have seen a gradual reduction in the duration of hospital stay after joint replacement," says Robert Greenhow, MD, of Peak Orthopedics & Spine in Lone Tree, Colo. "This has been based on less invasive and improved surgical techniques, use of regional anesthesia and peri-articular injections, less tubes and drains and a reduction in the use of narcotics."

Read more >
Read more on Becker's ASC Review

 

20,000 GMK Sphere implanted worldwide

20,000 GMK Sphere implanted worldwide

We are proud to announce that in October 2016 we reached the significant milestone of 20,000 GMK Sphere implanted worldwide.

Read more >

We are proud to announce that in October 2016 Medacta reached the significant milestone of

20,000 GMK SPHERE PROCEDURES WORLDWIDE!

The first GMK Sphere knee was implanted by Prof. Richard Field in London in November 2011.
More than 3,000 GMK Sphere were implanted in a selected number of centres during a 2 year post-marketing clinical evalution to responsively introduce the system into the market.

Following the official launch at the 7th M.O.R.E. International Symposium in Lugano in April 2014, GMK Sphere has encountered a huge worldwide success thanks to a capillary education network, including today more than 60 active Reference Centers all over the world.

Published papers show the GMK Sphere's potential to deliver a stable knee joint  (Scott G et al. Bone Joint Res, 2016;  Steinbrück et al. Clinical Biomechanics, 2016), which is proven to be a key factor to improve patient satisfaction after TKA (Pritchett JW, The Journal of Arthroplasty, 2011). 

Preliminary 2 Years clinical results confirm the GMK Sphere's potential to improve functional scores and patient reported outcomes.
(GMK Sphere. International, multi-centre, prospective, observational study - ODEP study, Richard Field, 8th M.O.R.E. International Symposium)

Read more references


 

Thousands of patients have been successfully treated with the GMK Sphere total knee system in more than 300 centres worldwide.

GMK SPHERE kept the promise to surgeons and patients: stability for life!

Learn more about GMK Sphere     Start with GMK Sphere

BECKER’S SPINE REVIEW: New data illustrates promise of Medacta's orthopedic surgery product line — 6 key notes, by Mary Rechtoris

BECKER’S SPINE REVIEW: New data illustrates promise of Medacta's orthopedic surgery product line — 6 key notes, by Mary Rechtoris

Medacta presented new data that showed the success of its orthopedic product line following the 8th M.O.R.E. International Symposium, a clinical educational meeting featuring more than 1,000 surgeons from around the globe. During the meeting in Switzerland, Richard Field, MD, orthopedic surgery professor at St. George's University of London, United Kingdoms, presented clinical results on Medacta's AMIStem hip implant study. The 421-patient study complied with the UK Orthopaedic Data Evaluation Panel recommendation, which evaluates an implant's performance and gives surgeons factors to consider when choosing implants for joint replacement procedures.

Read more >

 

First Surgeries with MySpine Low Profile Guide Following FDA Clearance

First Surgeries with MySpine Low Profile Guide Following FDA Clearance

Medacta International is proud to announce today the successful completion of the first U.S. surgeries by Dr. Raymond Golish in Jupiter, Fla. and Dr. Arnold Vardiman in San Antonio, Texas utilizing its innovative and proprietary 3D-printed MySpine Low Profile Guide, part of the company’s award-winning MySpine Patient Matched Technology, following its recent FDA clearance.

Read more >

Medacta International is proud to announce today the successful completion of the first U.S. surgeries by Dr. Raymond Golish in Jupiter, Fla. and Dr. Arnold Vardiman in San Antonio, Texas utilizing its innovative and proprietary 3D-printed MySpine Low Profile Guide, part of the company’s award-winning MySpine Patient Matched Technology, following its recent FDA clearance.

Demonstrating Medacta’s longstanding commitment to surgical education and training, Dr. Golish and Dr. Vardiman were introduced to the technology at one of Medacta’s industry-leading education forums focused on MySpine technology. “My work requires me to stay on the leading edge of new technologies and techniques for minimally invasive surgery,” Dr. Golish stated. “The MySpine Low Profile Guide sets a new standard for spine surgery and is well-positioned for safe, reproducible results in less invasive instrumentation of the lumbar and thoracic spine.”

Dr. Golish continued: “With the simple, yet thorough preoperative planning and 3D-printed spine guides, I was able to decrease overall operating room time and have better confidence in visualizing the screw trajectory while reducing the need for CT radiation. The patient from my first case is doing very well.”
Dr. Golish and Dr. Vardiman also utilized Medacta’s M.U.S.T. Pedicle Screw System, which requires only one set of dedicated instruments compatible with percutaneous, mini-open, and open procedures.

According to Prof. Claudio Lamartina the Medacta MySpine technology has the potential to combine accurate, safe screw placement whilst fulfilling additional requirements that an ideal pedicle screw placement system should guarantee. Low radiation exposure, reproducibility and no extra operative time are identified as key features of the MySpine technology.

Watch the MySpine video
 

Orthopedics This Week named Medacta’s MySpine Standard Profile a best New Technology for Spine Care when it was first released in 2014. The new Low Profile Guide builds on that success to better help spine surgeons identify pedicle entry points, screw trajectories, and implant specifications to potentially increase accuracy and outcomes. The recently launched MySpine Low Profile Guide lowers exposure for an even less invasive approach that is well suited for degenerative and deformity surgeries of the thoracic and lumbar regions. The MySpine Low Profile Guide received 501(k) clearance from the U.S. Food and Drug Administration in August 2016.

Our MySpine Low Profile Guide marks another step forward in Medacta’s continued focus on procedural innovation in spine surgery and adds to Medacta’s already impressive and extensive spine portfolio,” said Francesco Siccardi, Executive Vice President of Medacta International. “The Medacta difference stems from the strong emphasis we place on surgeon training and education, as well as better procedural focus to simplify the complex nature of spine procedures.”
 

Medacta’s MySpine products will be on display starting today at the North American Spine Society (NASS) Annual Meeting, Booth #1651, being held October 26-29, 2016 in Boston.
In addition to showcasing its MySpine technologies at NASS 2016, Medacta will hold an educational workshop, the “M.O.R.E. Spine Workshop: Discover Medacta Spine Innovations,” in the conference’s Yellow Lab on Thursday, October 27 at 5 p.m. 

Discover MySpine

 

Thanks to the M.O.R.E. Institute, Medacta International has become a leader for educating and supporting surgeons. Reference Centers, located throughout the world, provide the necessary educational experience and Medacta offers continuous support for surgeons, as well as constantly improving and developing the industries most specialised instrumentation platform.
The MySpine Low Profile Guide is another step to further reinforce Medacta’s leading position in medical education and innovative technologies development.

M.O.R.E. Institute

 

 

Residents are the future of orthopaedic research

Residents are the future of orthopaedic research

Medacta is proud to announce that, right now, will match dollar-for-dollar every resident donation.

Read more >

 

Today’s residents are more than just surgeons in training; they’re the future of orthopaedic research.

OREF offers grant programs designed to recognize the potential of new investigators and assist them on their research path. 
 

Following our 5-Year Commitment to Match Resident Donations to the Orthopaedic Research and Education Foundation,

Medacta is proud to announce that, right now,
will match dollar-for-dollar every resident donation
.

 

 

Double your impact now!
Donate at www.oref.org/medacta
or text “RES” to 91999

 

M.O.R.E. Institute

 

 

 

 

Medacta M.O.R.E. APP videotutorial

Medacta M.O.R.E. APP videotutorial

We are excited to announce the new Medacta M.O.R.E. APP videotutorial! The aim of this video is to show everyone the usefulness of this powerful application, designed specifically to assist you in accessing Medacta information!

Read more >

We are excited to announce the new Medacta M.O.R.E. APP videotutorial!

The aim of this video is to show everyone the usefulness of this powerful application,
designed specifically to assist you in accessing Medacta information!

With the Medacta M.O.R.E. APP, you have all of the product information you need at your fingertips, on your smartphone or tablet.
Managing travel information for your Medacta events has never been so easy.
Discover Medacta digital orthopaedics and neurosurgery educational material and keep updated with the latest company news and product content!
 

Watch the video   Medacta M.O.R.E. App  M.O.R.E. Institute

 

 

 

8th M.O.R.E. Symposium website

8th M.O.R.E. Symposium website

Following the success of our 8th M.O.R.E. International Symposium held in Lugano on April 22-23, 2016, we are delighted to announce the release of our newly re-designed congress website.

Read more >

Following the success of our 8th M.O.R.E. International Symposium held in Lugano on April 22-23, 2016, we are delighted to announce the release of our newly re-designed


congress website
8more.medacta.com


To re-live this memorable event, you will find:

  • the scientific program with video presentations of all the congress presentations
  • Medacta literature (“AMIS Publication Review”, “MyKnee Publication Review” and coming soon “M.O.R.E. Journal - 8th M.O.R.E. International Symposium - Congress Edition”)
  • a photo gallery and a dedicated area for press releases.


Through the Medacta M.O.R.E. App you can now access off-line all the video presentations.
 

8th M.O.R.E. website   Medacta M.O.R.E. App  M.O.R.E. Institute

 

 

 

MySpine technology, an accurate new tool for screw placement

MySpine technology, an accurate new tool for screw placement

We are pleased to highlight the interview of Prof. Claudio Lamartina on Spinal News International regarding the MySpine technology.

Read more >

We are pleased to highlight the interview of Prof. Claudio Lamartina on Spinal News International regarding the MySpine technology.
MySpine technology is based on custom-made Screw Placement Guides intended for use as anatomical perforating guides specific to a single patient’s anatomy to assist, intra-operatively, in the positioning of pedicle screws in the vertebral body.

See the MySpine portal


According to Prof. Claudio Lamartina the Medacta MySpine technology has the potential to combine accurate, safe screw placement whilst fulfilling additional requirements that an ideal pedicle screw placement system should guarantee. Low radiation exposure, reproducibility and no extra operative time are identified as key features of the MySpine technology.

Watch the MySpine video


The clinical evidence (cadaveric studies have already been published while randomised studies are on-going) supports the strength of the MySpine technology:

  • comparable performance with that of navigation-based techniques and greater accuracy than traditional freehand approaches in pedicle screw placement. [1,2,3]
  • reduces the post-operative morbidity and shortens the length of hospital stay[2]
  • reduces the exposure to ionizing radiations, both for the patient and for the staff[2]

The preliminary data, as Lamartina says, is encouraging: “the Medacta MySpine technology appears to be a path towards a more accurate pedicle screw implant and fewer related complications”.

Read more on Spine News   Discover MySpine

 

 

[1] Pedicle screw placement accuracy in thoracic and lumbar spinal surgery with a patient-matched targeting guide: A cadaveric study” by Lamartina and al.
[2] Spinal Neuronavigation and 3D-Printed Tubular Guide for Pedicle Screw Placement: A Really New Tool to Improve Safety and Accuracy of the Surgical Technique? by Dr. Landi et alter
[3] 3D Printed Tubular Guides for Pedicle Screw Placement: The Answer for the Need of a Greater Accuracy in Spinal Stabilization. The study has been published in the Orthop Muscular Syst 2015, 4:3 by Dr. Landi et alter

First MiniMAX hip stem implanted in Australia

First MiniMAX hip stem implanted in Australia

We are proud to announce the 1st MiniMAX hip stem was implanted in Australia through AMIS (Anterior Minimally Invasive Surgery) approach. The MiniMAX is an anatomical cementless stem engineered to provide the best fit and fill in the metaphyseal femur. First introduced in the market in 2007, it now reached proven clinical results, obtaining a survival rate at 5 years of 97.5% considering revision for any reason and 100% considering aseptic loosening as endpoint. The implant has been design to allow an easy and straightforward insertion, especially through AMIS approach.

Read more >

We are proud to announce that the 1st MiniMAX hip stem has been implanted in Australia through the AMIS (Anterior Minimally Invasive Surgery) approach.

The MiniMAX is an anatomical cementless stem engineered to provide the best fit and fill in the metaphyseal femur. First introduced to the market in 2007, it has now reached proven clinical results, obtaining a survival rate at 5 years of 97.5% considering revision for any reason and 100% considering aseptic loosening as endpoint[1]. The implant has been designed to allow easy and straightforward insertion, especially through the AMIS approach.

The MiniMAX in Australia fits into a product range of broadly used primary stems dedicated to AMIS. According to the Australian NJRR report[2], some Medacta hip implants have been amongst the most used for the past 5 years with a continuous growth. As an example, the Quadra-H is the 2nd most implanted cementless stem in Australia since 2011, with results as good as or even better than the most used total hip replacement systems worldwide. Also, from the latest available, the Quadra-H registered a growth of 27% in this market. The key of this success is the combination between the AMIS approach, dedicated hip implants and unique AMIS education courses that strongly reduced the surgeon’s learning curve. In Australia 95% of Medacta implants are performed through this approach.

Medacta International is the world leader for educating and supporting surgeons starting with anterior approach. Reference Centers, located throughout the world, provide the necessary AMIS educational experience and Medacta offers continuous support for surgeons, as well as constantly improving and developing the industries most specialised instrumentation platform. The MiniMAX stem is another step to further reinforce Medacta’s leading position in anterior approach development.
 

Discover MiniMAX   Discover Medacta AMIS Education program

 

MiniMAX is not FDA cleared.

[1] Dr. P.G. Vasina, Dr. R. Rossi, Dr. P. Palumbi, MiniMAX anatomical stem 5 years clinical outcomes.
[2] https://aoanjrr.sahmri.com/annual-reports-2015.

 

 

Medacta's Integrated Knee Platform to be Utilized in Prestigious Live Surgery Event

Medacta's Integrated Knee Platform to be Utilized in Prestigious Live Surgery Event

GMK Sphere, MyKnee and GMK Efficiency Single Use Instrumentation Take the Stage at Current Concepts in Joint Replacement Spring Meeting

Read more >

In today’s procedure, Dr. Manning will utilize Medacta’s integrated knee platform, including the GMK Sphere Medially Stabilized Knee, which is designed to deliver maximum functional stability to a replaced knee, allowing for improved patient satisfaction and reduced post-operative pain.

Prior to surgery, as part of his pre-operative 3D planning, Dr. Manning employed Medacta’s MyKnee Patient-Matched Technology to turn CT images of the patient’s unique anatomy into patient-specific cutting blocks. In the operating room, Dr. Manning will use Medacta’s GMK Efficiency Single Use Instruments – the third pillar of the platform debuted earlier this year.

Delivered sterile and ready for use, the GMK Efficiency instruments complement Medacta’s GMK Sphere and MyKnee to create a holistic platform that delivers even greater improvements in hospital and ambulatory surgery center (ASC) efficiency, allows for significant cost savings and supports positive patient outcomes.

Dr. Manning’s surgical presentation will be broadcast live today, Monday, May 23, 2016 at 2:40 p.m. PDT. Medacta’s GMK Sphere, MyKnee and GMK Efficiency Single Use Instruments will be on display at the company’s booth in the Exhibitor Hall.

Read more on BusinessWire

GMK Efficiency Single Use Knee Instruments Featured on Outpatient Surgery Magazine!

GMK Efficiency Single Use Knee Instruments Featured on Outpatient Surgery Magazine!

“As more outpatient facilities look to add total knee replacements to their caseload, a problem often arises: Reprocessing the procedure's big, heavy instrument trays can be too tough for smaller centers with limited sterile processing capabilities. To solve that problem, Medacta has created a single-use knee system.”

Read more >


 

"As more outpatient facilities look to add total knee replacements to their caseload, a problem often arises: Reprocessing the procedure's big, heavy instrument trays can be too tough for smaller centers with limited sterile processing capabilities. To solve that problem, Medacta has created a single-use knee system."

Read more on Outpatient Surgery Magazine

New Data and Milestones Back Medacta's Orthopedic Surgery Product Line Following 8th M.O.R.E. International Symposium

New Data and Milestones Back Medacta's Orthopedic Surgery Product Line Following 8th M.O.R.E. International Symposium

Proud to share new data and milestones of key products following the 8th M.O.R.E. Symposium in Lugano, Switzerland!

Read more >

 

 

The high adoption rate of Medacta’s surgical products and promising clinical data reviewed at the M.O.R.E. Symposium are testaments to the work we’re doing to improve the orthopedic experience both for patients and surgeons,” said Francesco Siccardi, Executive Vice President of Medacta International. “The positive feedback we’ve received for AMIStem and continued enthusiasm for GMK Sphere, MyKnee and MySpine suggest there is a clear need for products that combine meticulous design, responsible innovation and a commitment to health-economic sustainability.

  • More than 200,000 AMIS procedures completed and 100,000 AMIStem implants used, as new data demonstrate ODEP quality
  • More than 40,000 MyKnee procedures performed to date, providing superior function and accuracy
  • Over 15,000 GMK Sphere knees implanted since 2011, comparing favorably against other ODEP-rated implant designs
  • MySpine pedicle screw placement yields promising results

Read more on BusinessWire

 

 

More than 15,000 GMK Sphere!

More than 15,000 GMK Sphere!

We are proud to announce that, in April 2016 Medacta celebrated 15,000 GMK Sphere procedures performed worldwide!

Read more >

We are proud to announce that, in April 2016 Medacta celebrated 

15,000 GMK SPHERE PROCEDURES WORLDWIDE!

We are pleased to announce the important milestone of 15,000 GMK SPHERE!  This success has been obtained thanks to a capillary education network made up of more than 50 Reference Centers that are active in different Countries all over the world.

Published papers show the potential of GMK Sphere to deliver a stable knee joint  (Scott G et al. Bone Joint Res, 2016;  Steinbrück et al. Clinical Biomechanics, 2016), which is proven to be a key factor to improve patient satisfaction after TKA (Pritchett JW, The Journal of Arthroplasty, 2011).

Thousands of patients have been successfully treated with the GMK SPHERE total knee system in more than 200 centres worldwide.

GMK SPHERE kept the promise to surgeons and patients: stability for life!
 

Learn more about GMK Sphere
 

Start with GMK Sphere

 

More than 40,000 MyKnee!

More than 40,000 MyKnee!

We are proud to announce that in April 2016 Medacta celebrated 40,000 MyKnee procedures performed worldwide!

Read more >

We are proud to announce that in April 2016 Medacta celebrated 

MORE THAN 40,000 MYKNEE PROCEDURES WORLDWIDE!

Since its introduction to the market in 2009 the MyKnee Patient Matched Technology (PMT) has rapidly inspired the interest of hundreds of surgeons worldwide becoming a reliable routine procedure in their hospitals. More than 40,000 patients have been successfully treated worldwide with MyKnee, proving that not all PSI technologies are created the same and not all PSI technologies are made the same.

Many published papers prove the accuracy and effectiveness of MyKnee. In a study on 301 patients (Knee Surg Sports Traumatol Arthrosc, 2013), Koch et al showed that 87.6% patients were in the safe range of ±3 degrees from neutral post-operative HKA alignment. In a study on 222 knees (Knee Surg Sports Traumatol Arthrosc, 2014), Anderl et al  found that the use of MyKnee can help to reduce the number of outliers compared to conventional instruments (9.6% Vs. 22.2%).

MyKnee Patient Matched Technology: this one really works!
 

Learn more about MyKnee

Start with MyKnee

 

 

200,000 AMIS worldwide!

200,000 AMIS worldwide!

It is with great pride and pleasure that Medacta announces a new milestone achievement: more than 200,000 AMIS procedures worldwide!

Read more >

It is with great pride and pleasure that Medacta announces a new milestone achievement:

MORE THAN 200,000 AMIS PROCEDURES WORLDWIDE!

AMIS is a hip replacement technique that follows both an intermuscular and internervous path to greatly decrease damage to periarticular structures while preserving tissue and which is supported by the industry’s most detailed surgeon training protocol. 
Not only a surgical technique but a complete set of services which provides efficiency and potentially economic and commercial advantages to the hospital & surgeon.

MORE THAN 100 PUBLICATIONS AS CLINICAL EVIDENCE[1]


Read more

 

 

[1] AMIS Publication Review – M.O.R.E. Journal Supplement, April 2016. 99.98.publ rev.01

[2] Field R. et al. - Prospective randomised controlled clinical trial comparing THA performed either through a posterior approach or AMIS using gait analysis - M.O.R.E. Journal 7th M.O.R.E. International symposium, Congress edition, Lugano, Switzerland, April 11-12, 2014.
 

 

 

 

AMISTEM-H awarded ODEP 5A rating

AMISTEM-H awarded ODEP 5A rating

We are proud to announce that AMIStem-H was just awarded the ODEP 5A rating, confirming the promising results of the 3A* score of the last years.

Read more >

We are proud to announce that AMIStem-H was just awarded the ODEP 5A rating, confirming the promising results of the 3A* score of the last years.

5A ODEP rating means that the AMIStem-H has been evaluated through a multicentric study, with a minimum cohort of 250 hips, demonstrating Kaplan – Meier survivorship data better than, or equal to, 95% at the five year benchmark.

This excellent rating is confirmed and outmatched by a study on AMIStem-H – 5 years preliminary clinical outcomes, performed by the following centres:

  • South West London Elective Orthopaedic Centre, Epsom (UK) - Prof. Richard Field
  • Universitätsklinik Balgrist, Zürich (CH) - Prof. Claudio Dora
  • Northampton General Hospital, Northampton (UK) - Mr. Edward Crawfurd

The study includes 421 patients and the AMIStem-H survival rate at 5 years after surgery resulted in 97.75%, with any reason for revision as endpoint.

 

 Discover AMIStem

 

(ODEP: ORTHOPAEDIC DATA EVALUATION PANEL) 
Latest ODEP ratings can be found at www.odep.org.uk

 

OUTPATIENT SURGERY MAGAZINE: Cool New Toys for Your Orthopods, by Christopher Bensen, MD

OUTPATIENT SURGERY MAGAZINE: Cool New Toys for Your Orthopods, by Christopher Bensen, MD

As more outpatient facilities look to add total knee replacements to their caseload, a problem often arises: Reprocessing the procedure's big, heavy instrument trays can be too tough for smaller centers with limited sterile processing capabilities. To solve that problem, Medacta has created a single-use knee system.

Read more >
Medacta Spotlighted Leading Knee, Hip, Spine and Hip Preservation Surgical Practices and Innovations at the 8th M.O.R.E. International Symposium

Medacta Spotlighted Leading Knee, Hip, Spine and Hip Preservation Surgical Practices and Innovations at the 8th M.O.R.E. International Symposium

Reflected long-standing commitment to surgical education and training for improved patient outcomes. Coincided with 200,000th Anterior Minimally Invasive Surgery procedures, 100,000th AMIStem Hip implantation, 40,000th MyKnee Patient Matched Technology Instrumentation, presentation of the New MySpine Low Profile Pedicle Screw Guidance Technology.

Read more >

 

 

Reflected long-standing commitment to surgical education and training for improved patient outcomes. 

Coincided with:

  • 200,000th Anterior Minimally Invasive Surgery procedures,
  • 100,000th AMIStem Hip implantations,
  • 40,000th MyKnee Patient Matched Technology Instrumentation,
  • presentation of the New MySpine Low Profile Pedicle Screw Guidance Technology


This year’s Symposium featured distinct tracks dedicated to knee, hip, spine, and hip preservation technologies and techniques, including over 100 presentations and round table discussions over the two-day period.

The Faculty included more than 120 Surgeons from all over the world. Prof. Michael Freeman was the Honorary Chairman of the Joint Program with Chitranjan S. Ranawat (New York, USA) delivering the Knee Keynote address. Frédéric Laude, MD (Paris, France) and J. A. Rodriguez, MD (New York, USA) served as Chairmen of the Hip Program; David M. Manning (Illinois, USA) and Philippe Neyret (Lyon, France) chaired the Knee Program; Dezsö Jeszenszky (Zurich, Switzerland) served as Honorary Chairman of the Spine Program and Larry Khoo delivered the Keynote lecture on MIS in Spine, supported by Session Chairmen Evalina Burger, Zsolt Fekete, Angus Gray, Christophe Heyde, Claudio Lamartina, Scott Leary, Michael Rauschmann, William Smith; and Marc Safran (California, USA) and Michael Dienst (Munich, Germany) chaired the Hip Preservation Program.

Special guest Richard F. Santore served as Orthopaedic Research and Education Foundation (OREF) Ambassador and opened the Hip Program on Saturday, April 23. Read more on Bussinesswire
 

Visit our website

 

 

The new Medacta M.O.R.E. APP in now available!

The new Medacta M.O.R.E. APP in now available!

The Medacta M.O.R.E. APP is our new application for the Medacta Orthopaedic Research and Education Institute.

Read more >

We are excited to announce the Medacta M.O.R.E. APP!

The Medacta M.O.R.E. APP is our new application for the Medacta Orthopaedic Research and Education Institute.

With this cross-platform app you have 24/7 access to the most important information regarding the M.O.R.E. Institute and Medacta
events (Congresses, Learning Centers, etc.), along with all the Medacta educational material, from an iOS or Android based tablet or mobile
device, both online and offline!

The most important features:

Medacta events

  • Event program, faculty details and presentation abstracts
  • Interactive map to easly locate hotels and venues
  • Contact information
  • Travel documents
  • Real-time voting
     

Medacta educational material

  • Highlights - to obtain the most important details
  • Latest content - to always be up-to-date
  • On demand content - to download only what you want
  • Offline content - to access your content anytime anywhere

 

 

 

EFORT FOUNDATION: Medacta Visiting Fellowship 2016

EFORT FOUNDATION: Medacta Visiting Fellowship 2016

Applications for the Medacta 2016 visiting fellowship are open throughout the year to orthopaedic specialists based on their national regulations, as well whether they are younger than 45 years of age or are residents in their last year of residency.

Read more >

Applications for the Medacta 2016 visiting fellowship are open throughout the year to orthopaedic specialists based on their national regulations, as well whether they are younger than 45 years of age or are residents in their last year of residency.

Candidates may apply for medium-term or long-term fellowships in order to visit one of the recognized hosting centers.

 

Read more on Healio.com

Apply for 2016

EFORT website

 

 

 

Solvay and Medacta Complete Unique Study Comparing Carbon Footprint of Single-Use and Reusable Surgical Instruments

Solvay and Medacta Complete Unique Study Comparing Carbon Footprint of Single-Use and Reusable Surgical Instruments

As industry-leading innovators and collaborators, both Solvay and Medacta have been at the forefront of the trend toward single-use medical instrumentation.

Read more >

“As industry-leading innovators and collaborators, both Solvay and Medacta have been at the forefront of the trend toward single-use medical instrumentation.
Despite the tremendous promise of the single-use concept for reducing the frequency of hospital acquired infections, concerns over increased waste have led to the perception that single-use instrumentation is less environmentally friendly than traditional systems,” said Bianca Shemper, sustainability manager for Solvay Specialty Polymers.

“With Medacta’s help, we methodically explored those concerns to determine whether the alleged environmental impact of a single-use instrument kit outweighed its clear potential benefits. Partnerships like this emphasize Solvay’s commitment to taking a leadership role in sustainable chemistry and environmental responsibility to help our customers foster environmentally friendly yet highly competitive new solutions.”

Read the press release


Follow us on twitter:

@medacta

 


 

 

 

Medacta Showcases Latest Surgical Innovations at the American Academy of Orthopaedic Surgeons Annual Meeting

Medacta Showcases Latest Surgical Innovations at the American Academy of Orthopaedic Surgeons Annual Meeting

At the AAOS, Medacta showcased its latest surgical innovations, including its GMK Efficiency Single Use Knee Instruments and Mpact Dual Mobility Acetabular System, and provided an update on its pioneering MySpine Patient-Matched Technology.

Read more >

“The practice of orthopaedic surgery is constantly evolving, and Medacta stands ready to equip surgeons with innovative, effective tools for in-hospital and ambulatory surgery centers alike,” said Francesco Siccardi, Executive Vice President of Medacta International.

“At this year’s meeting, we provided an update on our GMK Efficiency Single Use Instruments for Knee Replacement, which have the potential to simplify the surgical procedure and provide benefits to the patient and facility while remaining carbon neutral.
We also showcased for the first time, the Mpact Dual Mobility System for total hip replacement, which is built upon 40 years of clinical heritage and has been designed to provide unmatched stability and an exceptionally high range of motion, while potentially lowering dislocation rates.
Our award-winning MySpine has also been on display as the first product available in the U.S. to produce tailor-made patient-matched guides for the spine vertebrae using proprietary CT scan algorithms and sophisticated 3D medical printing technology.”
 

 Read more on BusinessWire

Discover our products

 


 

 

 

CORRIERE DEL TICINO: ‘Cutting the ribbon’ for Medacta in Rancate

CORRIERE DEL TICINO: ‘Cutting the ribbon’ for Medacta in Rancate

Medacta International, leader in the field of orthopaedics, launches its new building in Via alla Rossa, Rancate.

Read more >

MENDRISIO – Following its Headquarters in Balerna, Medacta International SA opens the doors of its new establishment in Via alla Rossa, Rancate. This expansion, that was inaugurated yesterday, incorporates 49 people. However, the number of employees is set to rise! «By December, the goal is to employ around 90 people – as announced by Dr. Alberto Siccardi, the President of the company, whilst introducing the business to the people who were there to observe the opening of the new building. To help develop the company further, approximately thirty new hires are planned by 2017, including five engineers. In Rancate, Medacta International will mainly deal with spine products and instruments, while the production of prosthesis for hips and knees will remain in Balerna.

Read more on Corriere del Ticino

 

 

 

100,000 cementless AMIStem implanted worldwide!

100,000 cementless AMIStem implanted worldwide!

We are proud to announce that, in March 2016, the AMIStem System reached the significant milestone of 100,000 cementless femoral stems implanted worldwide.

Read more >

We are proud to announce that, in March 2016, the AMIStem System reached the significant milestone of 100,000 cementless femoral stems implanted worldwide!

The AMIStem System is the first stem specifically designed for AMIS (Anterior Minimally Invasive Surgery). Launched in 2009, it has since encountered huge success which has led to this important milestone. 

The AMIStem  has proven to be an effective and reliable femoral stem appreciated by surgeons all over the world.

 Discover AMIStem


 

 

 

10,000 GMK SPHERE implanted worldwide!

10,000 GMK SPHERE implanted worldwide!

We are proud to announce that, in November 2015, we reached the significant milestone of 10,000 Sphere knees implanted worldwide!

Read more >

We are proud to announce that, in November 2015, we reached the significant milestone of 10,000 Sphere knees implanted worldwide

The first implantation was performed by Prof. Field in London in 2011 and after that more than 3,000 Sphere have been implanted in a selected number of Centres during a 3 year trialists phase to responsively introduce the system into the market. 

Following the official launch at the 7th M.O.R.E. International Symposium in Lugano in April 2014, GMK Sphere has definitely encountered wide success that has led to this important result.
 

Discover GMK Sphere



 

 

 

1st M.O.R.E. ASIAN AMIS LEARNING CENTER

1st M.O.R.E. ASIAN AMIS LEARNING CENTER

We are proud to announce that on November 23rd – 24th 2015 Medacta successfully held the 1st M.O.R.E. ASIAN AMIS LEARNING CENTER in Singapore.

Read more >

Medacta and the M.O.R.E. Institute are proud to announce that the 1st M.O.R.E. ASIAN AMIS LEARNING CENTER was held on November 23rd – 24th 2015 at the Khoo Teck Puat Advanced Surgery Training Centre in Singapore.

The M.O.R.E. Institute celebrates a new milestone for the AMIS Education Platform, strengthening further its leading position in providing education of the anterior approach worldwide!

The Khoo Teck Puat Advanced Surgery Training Centre is one of the most technologically advanced and prestigious training centres on the global stage, making Singapore one of the world’s leading centres for surgical training.

Its 1000 sqm area is equipped with cutting edge facilities and devices to create and deliver outstanding educational programmes for junior and advanced surgical trainees. The cutting edge technologies of the ASTC together with the AMIS educational programmes define the standards of surgical training, the needs of our continuously evolving medical professionals and, ultimately, the benefits for our patients.
 

ORTHOPEDICS THIS WEEK: Medacta International. Founded by a Patient, Exceptional Through Training, by Elizabeth Hofheinz, M.P.H., M.Ed.

ORTHOPEDICS THIS WEEK: Medacta International. Founded by a Patient, Exceptional Through Training, by Elizabeth Hofheinz, M.P.H., M.Ed.

Francesco Siccardi, executive vice president of Medacta International and son of the founder, tells OTW, “Years ago I watched my father suffer after undergoing a total hip replacement. He and I both knew that there had to be a better way. We could see the advantages of the anterior hip approach, and we were personally motivated to find a way to give patients a superior surgical experience..."

Read more >


 

Medacta International: Founded by a Patient, Exceptional Through Training
 

Francesco Siccardi, executive vice president of Medacta International and son of the founder, tells OTW,
“Years ago I watched my father suffer after undergoing a total hip replacement. He and I both knew that there had to be a better way.
We could see the advantages of the anterior hip approach, and we were personally motivated to find a way to give patients a superior surgical experience. To that end, we partnered with esteemed French surgeon Frédéric Laude, M.D., one of the original innovators of the anterior approach. Together, we created the AMIS (anterior minimally invasive surgery) Technique, a muscle-sparing approach that has resulted in shorter hospital stays, faster rehabilitation time, and a quicker return to daily activities.”

“Medacta has an educational program that allowed me to learn this technique comprehensively and implement it in a safe manner. The anterior approach does have a steep learning curve and it can be frustrating. With the Medacta program, the surgeon first goes to a Reference Center to observe a surgeon who is proficient in the technique. After the Reference Center visit, the trainee can then participate in an introductory course with didactic classroom sessions and cadaver lab sessions. If he or she decides to adopt the technique, Medacta arranges for a proctoring surgeon to be on hand in the OR for their first cases and as many times after this as the trainee feels is necessary,” says training participant-turned-AMIS educator, Peter Thadani, M.D., who is with the Illinois Bone and Joint Institute.

Read more on Orthopedics This Week

 

Medacta Celebrates 200th AMIS Learning Center: Global Education, Personal Impact

Medacta Celebrates 200th AMIS Learning Center: Global Education, Personal Impact

The night before the 200th AMIS Learning Center, Medacta will be sponsoring an event on VuMedi at 6pm MDT. This live panel discussion will feature a global faculty, Dr. Frederic Laude (Paris, FR) and Dr. Chien-Wen Liew (Adelaide, AUS), moderated by Dr. Tyler Goldberg (Austin, TX). This event will focus on the how a global education platform has had an impact on a personal level.

Read more >

In 2004, Medacta International introduced a revolutionary education platform designed to introduce, train, and support surgeons interested in learning the AMIS technique. This program was unlike any other program supported by industry in training surgeons on a technique. The AMIS Educational Program was designed to support surgeons throughout the learning curve required for a new technique.  Instead of simply holding cadaver labs then trusting that surgeons were sufficiently trained, Medacta developed the program to insure that adoption of the technique was successful for surgeons and would become part of the regular practice in a safe and effective manner.

11 years after the introduction of the AMIS Educational Program, Medacta is celebrating its 200th AMIS Learning center on October 1st and 2nd in Denver, CO. The night before the 200th AMIS Learning Center, Medacta will be presenting an event on VuMedi at 6pm MDT.  This live panel discussion will feature a global faculty, Dr. Frederic Laude (Paris, FR) and Dr. Chien-Wen Liew (Adelaide, AUS), moderated by Dr. Tyler Goldberg (Austin, TX).  This event will focus on the how a global education platform has had an impact on a personal level. Finally, on October 2nd and 3rd, Medacta will be hosting the 2nd AMIS Advanced Users Course in Denver. The goal of this course is to bring together surgeons that have been utilizing the AMIS technique beyond the learning curve and provide a venue for discussing expanding patient selection, revision techniques, and utilizing the AMIS technique in an outpatient setting.

Medacta is dedicated to supporting surgeons throughout their growth in adoption of the AMIS technique. In 2016, Medacta will introduce more educational opportunities to the AMIS Educational Program. Training on revision techniques and programs focused on outpatient total joint replacement in hip and knee replacements will be new additions to Medacta’s robust educational platform.

This webcast will be presented on October 1st, 2015 at 6 PM MDT Denver.

Please consider your local time:

  • October 2nd, 2015 at 02:00 CEST Lugano
  • October 2nd, 2015 at 09:00 JST Tokyo
  • October 2nd, 2015 at 10:00 AEST Sydney
     

Subscribe to the event!
 

This webcast will be available in the Webinars section, in the archived events on VuMedi.

If you don't have an account, please register on VuMedi now!

Don't forget to follow us on VuMedi!

 

 

200 M.O.R.E. AMIS Learning Center - Global Education, Personal Impact

200 M.O.R.E. AMIS Learning Center - Global Education, Personal Impact

It is with great pride and pleasure that Medacta announces a new milestone for the M.O.R.E. Institute and the AMIS Education Platform, which once again strengthens its leading position in Anterior approach education!

Read more >




 

This Autumn, 11 years after the introduction of the AMIS Education Program, Medacta will celebrate the 200th AMIS Learning Center with a global scale event, involving 3 continents: Europe, America and Oceania.

 

This important event will be held in 3 different countries to celebrate this achievement around the world:

  • September 24, 25 – Zurich – Switzerland        
  • October 1, 2 – Denver – Colorado (US)          
  • October 30 – Sydney – Australia        
     

          


Education plays an integral role when adapting a new technique into a surgical practice. This is particularly true with the anterior approach to hip replacement, which has often been cited as being difficult for surgeons to incorporate due to a steep learning curve and complications occasionally experienced during the learning process. The key to shortening the learning curve and reducing the risk of complications during this period is a program developed by Medacta where the surgeon has a network in place to assist him/her during this critical time.      
With the aim of continuously supporting surgeons, this event will focus on how a global education platform has had an impact on a personal level.


With the 200th AMIS Learning Center the M.O.R.E. Institute can proclaim that over 2,600 Surgeons have attended an AMIS Course. To date, over 3,500 surgeon to surgeon visits have been made, supporting the start and routine use of the AMIS technique in over 1,100 hospitals worldwide.


We would like to thank all the Surgeons who have supported us with their time, knowledge and passion for the educational activity that has made the AMIS technique a new reference for Hip Replacement around the world.
 

 

 

Enhancing Sagittal Stability in TKA featuring the GMK Sphere Knee - Webcast Replay Available

Enhancing Sagittal Stability in TKA featuring the GMK Sphere Knee - Webcast Replay Available

Medacta, Northwestern Medicine and VuMedi conducted a webcast featuring the GMK Sphere knee on July 28. The webcast replay is now available in the VuMedi webinar archive section.

Read more >

Medacta, Northwestern Medicine and VuMedi conducted a webcast featuring the GMK Sphere knee on July 28. 
The webcast replay is now available in the webinar archive section.

The event offered a didactic session hosted by Dr. David Manning, followed by a surgical demonstration featuring the GMK Sphere and
MyKnee Patient Matched Technology with Dr. Manning and Dr. Matthew Beal.
 

This webcast is now available in the webinar archive section! 
Click here to watch the archived version of "Enhancing Sagittal Stability in TKA featuring the GMK Sphere Knee"
 

During his surgical demonstration, Dr. Manning presented compelling data that challenges orthopedic surgeons to examine current designs in total knee arthroplasty - seeking an option that may allow for enhanced sagittal stability and function.

If you don't have an account, please register on VuMedi now!

Don't forget to follow us on VuMedi!

 

 

 

1st M.O.R.E. Japanese Symposium website

1st M.O.R.E. Japanese Symposium website

Following the success of our 1st M.O.R.E. Japanese Symposium in April, we are delighted to announce the Congress website: www.1more-jpn.medacta.com We have created this portal in order to re-live this memorable event via the web.

Read more >

Following the success of our 1st M.O.R.E. Japanese Symposium in April, we are delighted to announce the Congress website: www.1more-jpn.medacta.com
We have created this portal in order to re-live this memorable event via the web.
Regarding the scientific content, you will find all  the congress speeches, including the 2 live surgeries performed from the Aihara Hospital in Osaka and Emoto Hospital in Fukuoka.
Medacta literature, M.O.R.E. Journal – Abstract Book – Fukuoka edition, will be available soon.

Click here for information regarding the M.O.R.E. Institute
Click here to visit the 1st M.O.R.E. Japanese Symposium website.
 

 

 

 

8th M.O.R.E. International Symposium - 22/23 April 2016 - Lugano

8th M.O.R.E. International Symposium - 22/23 April 2016 - Lugano

As part of Medacta’s ongoing commitment to Continuous Medical Education, we are announcing the: 8th M.O.R.E. International Symposium - April 22 - 23 2016 - http://8more.medacta.com The Symposium will be held in Lugano, Switzerland, the picturesque city where Medacta is headquartered.

Read more >

As part of Medacta’s ongoing commitment to Continuous Medical Education, we are announcing the:

8th M.O.R.E. International Symposium
April 22nd – 23rd 2016

The Symposium will be held in Lugano, Switzerland, the picturesque city where Medacta is headquartered.

This course will be a unique and exciting event, scientifically and educationally focused on the evolution of patient expectations and on exploring factors that optimise survivorship, function and patient satisfaction.

For Joint, we can proudly announce that Prof. Michael Freeman (Honorary Consultant at The Royal London Hospital, London, UK) has agreed to serve as Honorary Chairman; Dr. Frédéric Laude (CMC Paris V, Paris, France) and Dr. Jose A. Rodriguez (Lenox Hill Hospital, New York, USA) will Chair the Hip program while Dr. David W. Manning (Northwestern Memorial Hospital, Chicago, USA) and Prof. Philippe Neyret (Centre Albert Trillat, Lyon, France) will Chair the Knee program. Dr. Chitranjan S. Ranawat (Hospital for Special Surgery, New York, USA) has accepted an invitation to participate as Keynote Speaker.

In parallel to the Joint sessions, there will be two days dedicated to Spine: Dr. med. Deszö Jeszenszky (Schulthess Klinik Zürich, Switzerland) has agreed to serve as Honorary Chairman; Dr. A. Gray (Sydney Children’s Hospital, Randwick, Australia), Dr. Richard Guyer (Texas Back Institute, Plano, USA), Prof. Dr. med. Christoph.-E. Heyde (University Hospital Leipzig, Germany), Dr. Larry Khoo (Good Samaritan Hospital, Los Angeles, USA), Prof. Claudio Lamartina (Galeazzi Instituto Ortopedico, Milan, Italy), Dr. Scott P. Leary (Scripps, San Diego, USA) and Prof. Dr. med. M. Rauschmann (University Hospital Frankfurt, Germany) will Chair the Spine sessions.

For further information and future updates, visit the official website or write to 8more@medacta.com

Discover the last edition.

 

 

The GMK Sphere Knee Experience – A Live Surgical Demonstration

The GMK Sphere Knee Experience – A Live Surgical Demonstration

Join Medacta, Northwestern Medicine and VuMedi for a surgical demonstration featuring the GMK Sphere Knee System with MyKnee Patient Matched Technology. This webcast will be presented on July 28th, 2015 at 5 PM PDT Los Angeles.

Read more >

Join Medacta, Northwestern Medicine and VuMedi for a surgical demonstration featuring the GMK Sphere Knee System with MyKnee Patient Matched Technology

This webcast will be presented on July 28th, 2015 at 5 PM PDT Los Angeles.
 

Hosting the event will be Dr. David Manning, Associate Professor and Vice Chair of the Department of Orthopaedic Surgery at Northwestern University in Chicago, Illinois. The session will be moderated by Dr. Matthew Beal, Assistant Professor of Orthopaedic Surgery and Program Director for the Orthopedic Surgery Residency Training Program at Northwestern University.

Please consider your local time:

  • July 29th, 2015 at 02:00 CEST Lugano
  • July 29th, 2015 at 09:00 JST Tokyo
  • July 29th, 2015 at 10:00 AEST Sydney
     

Subscribe to the event!
 

This webcast will be available in the Webinars section, in the archived events on VuMedi.

If you don't have an account, please register on VuMedi now!

Don't forget to follow us on VuMedi!

 

 

 

25 Spine Device Awards | 2015

25 Spine Device Awards | 2015

These 25 spine devices received the 2015 Becker's Healthcare Spine Device Award.

Read more >

These 25 spine devices received the 2015 Becker's Healthcare Spine Device Award.
 

MySpine from Medacta.
The MySpine Patient-Matched Technology uses three-dimensional reconstruction and rapid three-dimensional printing technology to create patient-specific guides. The technology is used during complicated spinal deformity repairs. The MySpine technology is designed to increase efficiency and accuracy with the guides helping identify optimal screw trajectories and entry points into specific vertebrae. 
 

Read more on Becker's Spine Review

 

 

Medacta Announces 5-Year Commitment to Match Resident Donations to the OREF

Medacta Announces 5-Year Commitment to Match Resident Donations to the OREF

Medacta International Announces 5-Year Commitment to Match Resident Donations to the Orthopaedic Research and Education Foundation.

Read more >


Medacta made a donation to the Orthopaedic Research and Education Fund to support future researcher endeavors and clinical trials.
Medacta agreed to match every resident gift dollar-for-dollar over the next five years. The funds will support OREF in offering unique opportunities and initiatives to improve surgical outcomes.

Furthering surgical research and education has been a focus for Medacta since inception, and we believe it’s one of the most crucial ways to drive new solutions, improve patient safety and reduce the cost of orthopaedic care and recovery,” said Francesco Siccardi, executive vice president of Medacta International. “Medacta is pleased to support OREF and further grant opportunities that enhance resident and fellowship training and advance the newest frontiers of orthopaedic discovery.”

Read more on BussinessWire

Read more on Becker's spine review

Visit oref.org

 

 

Medacta Launches Channel on VuMedi

Medacta Launches Channel on VuMedi

In our effort to provide customized and continuous support to our surgeon partners, we have launched the Medacta Channel on VuMedi.com. This new channel will be provided as an effort to complement Medacta’s unparalleled surgeon education and training programs.

Read more >

The surgeon is never alone with Medacta!

In our effort to provide customized and continuous support to our surgeon partners, we have launched the Medacta Channel on VuMedi.com. This new channel will be provided as an effort to complement Medacta’s unparalleled surgeon education and training programs.
Upon its introduction, this channel will offer multiple surgical videos provided by members of the AMIS Educational Board, proceedings of the 7th M.O.R.E Symposium held in 2014, as well as multiple videos demonstrating the use of MyKnee Patient Matched Technology, the GMK Sphere Knee System and MySpine Patient Matched Technology.

For the past 6 years, VuMedi has focused on physician education in orthopedics, cardiovascular, radiology, neurosurgery and more recently dental and oral maxillofacial surgical specialties.  The end result has seen VuMedi become the “YouTube” for specialist physicians the world over
It is the largest medical community of this sort in the world, with surgeons routinely visiting VuMedi to watch expert videos, interact in discussions, participate in live webinars, and potentially receive continuing medical education credits.

Register to VuMedi Follow us on VuMedi

 

 

First Surgeries with MySpine Patient-Matched Technology in the United States

First Surgeries with MySpine Patient-Matched Technology in the United States

Medacta USA announced the completion of the first successful surgeries in the United States utilizing MySpine Patient-Matched Technology.

Read more >

MySpine® utilizes Medacta’s proven 3D-reconstruction and rapid 3D-printing technologies to produce customized patient-specific surgical guides intended to support spinal surgeons during the most complex deformity cases. Designed to better help surgeons identify pedicle entry points, screw trajectories, and implant specifications, MySpine® is intended to potentially increase the accuracy, efficiency, and outcomes of spinal procedures.

Read more on Bussinesswire

Discover how it works on Medacta.tv

 

 

MySpine has been awarded as the BEST NEW TECHNOLOGY FOR SPINE CARE IN 2014

MySpine has been awarded as the BEST NEW TECHNOLOGY FOR SPINE CARE IN 2014

MySpine was selected as a Best New Technology in Thoracolumbar Care on the basis of its originality, clinical relevance and likelihood of improving patient outcome.

Read more >

MySpine® utilizes Medacta’s proven 3D-reconstruction and rapid 3D-printing technologies to produce customized patient-specific surgical guides intended to support spinal surgeons even during the most complex deformity cases. MySpine®  was designed to better help spine surgeons identify pedicle entry points, screw trajectories, and implant specifications to potentially increase accuracy and outcomes.  

MySpine® is the newest addition to our line of Patient-Matched Technology solutions and its recognition further exemplifies our vision and firm commitment to pioneering advancements that have a positive impact on spinal surgeons, patients, and healthcare across the board,” said Francesco Siccardi, Executive Vice President, Medacta International. “We are honored that MySpine® was recognized by Orthopedics This Week and we look forward to bringing more responsible ingenuity and innovations to market.” 

Read more on This Week Orthopedics

Discover how it works on Medacta.tv

 

 

Medacta featured on the Bone & Joint Journal website!

Medacta featured on the Bone & Joint Journal website!

We are proud to inform you that the 7th M.O.R.E. Symposium Report has been published in The Bone & Joint Journal June issue.

Read more >

We are proud to inform you that the 7th M.O.R.E. Symposium Report has been published in The Bone & Joint Journal June issue. This report is also available in the Industry News section of the Bone & Joint Journal Website.

 

 

Orthopedics Leader Medacta International Opens New U.S. Headquarters in Chicago

Orthopedics Leader Medacta International Opens New U.S. Headquarters in Chicago

Medacta USA relocated its headquarters from Southern California to better support the company’s expansion into the U.S. orthopedics market. Since receiving initial FDA regulatory clearances in 2009, Medacta USA has experienced rapid year-over-year growth, and its knee, hip, and spine products have received accolades from surgeons nationwide. The company will continue to innovate with several new product introductions this year.

Read more >

Chicago Mayor Rahm Emanuel and Medacta USA President Eric Dremel today announced the official opening of Medacta USA’s new headquarters in Chicago. Medacta USA is a subsidiary of Medacta International, a privately held, family-owned global leader in the design of innovative joint replacement and spine surgery products. The 20,000 square foot facility located at 1556 West Carroll Avenue is expected to bring more than 50 jobs to the city, uniting Medacta USA’s operations, product development, sales, and marketing functions together in a city and region known for its deep medical technology roots.

“I am pleased to welcome Medacta International’s new U.S. headquarters to Chicago,” said Mayor Rahm Emanuel. “One of the main objectives of the Plan for Economic Growth and Jobs is to ensure that companies like Medacta see Chicago as the ideal location for new corporate headquarters. This is proof that our efforts to create new jobs and grow the city’s economy are working.”

Medacta USA relocated its headquarters from Southern California to better support the company’s expansion into the U.S. orthopedics market. Since receiving initial FDA regulatory clearances in 2009, Medacta USA has experienced rapid year-over-year growth, and its knee, hip, and spine products have received accolades from surgeons nationwide. The company will continue to innovate with several new product introductions this year.

Read more on Bussinesswire

 

 

7th M.O.R.E. Symposium website

7th M.O.R.E. Symposium website

Following the success of our 7th M.O.R.E. Symposium in Lugano in April, we are delighted to announce the Congress website: www.7more.medacta.com

Read more >

 

Following the success of our 7th M.O.R.E. Symposium in Lugano in April, we are delighted to announce the Congress website: www.7more.medacta.com

We have created this portal in order to re-live this memorable event via the web.

Regarding the scientific content, you will find all  the congress speeches, including the 2 live surgeries performed from the Uniklinik Balgrist in Zurich; the posters that were displayed in the congress foyer and Medacta literature that includes the M.O.R.E. Journal - 15th Anniversary - Special Edition and the M.O.R.E. Journal - 7th M.O.R.E. International Symposium - Congress Edition.

Click here for information regarding the M.O.R.E. Institute

Click here to visit the 7th M.O.R.E. Symposium website.

 

 

EFORT Industry Award 2014 for Medacta

EFORT Industry Award 2014 for Medacta

In recognition of Medacta’s commitment to support Continuous Medical Education, Medacta will receive the “EFORT Industry Award 2014” during the EFORT Congress opening ceremony on June 4th, from 12 to 12.30, in the main Auditorium “London”. This prize acknowledges Medacta’s loyal support of the EFORT FOUNDATION Fellowship Programmes.

Read more >

In recognition of Medacta’s commitment to support Continuous Medical Education, Medacta will receive the “EFORT Industry Award 2014” during the EFORT Congress opening ceremony on June 4th, from 12 to 12.30, in the main Auditorium “London”.

This prize acknowledges Medacta’s loyal support of the EFORT FOUNDATION Fellowship Programmes.

The 15th EFORT – European Federation of Orthopaedics and Traumatology – Congress will take place this year from June 4th–6th in London, UK.
Unique to this meeting will be the incorporation of the BOA’s own cyclical education programme which will also be open to participants. The theme of the meeting as a whole is patient safety…and safety and restorative responsibility is Medacta’s focus and passion: Medacta knows that improving lives requires meticulous design and responsible innovation.

Medacta invests in on-going medical education and proctorship, more than $57 million in the last five years, to enhance surgical proficiency and patient outcomes. The focus on education is evident with over 1600 surgeons trained worldwide through several channels: the M.O.R.E. Institute, the EFORT Fellowship Programme, the AOA Fellowship Programme, the EKA Fellowship Programme...and various other activities to support surgeon education. 

With Medacta International the surgeon is never alone!
 

Click here for information regarding the M.O.R.E. Institute

Click here for information regarding the EFORT Fellowship Programme

 

 

Eric Dremel Appointed President of Medacta USA, Inc.

Eric Dremel Appointed President of Medacta USA, Inc.

Medacta International, a privately held, family-owned global leader in the design of innovative joint replacement and spine surgery products, today announced that Eric Dremel has been named president of the company’s United States subsidiary, Medacta USA, Inc., headquartered in Chicago, Illinois.

Read more >

"Medacta® International, a privately held, family-owned global leader in the design of innovative joint replacement and spine surgery products, today announced that Eric Dremel has been named president of the company’s United States subsidiary, Medacta USA, Inc., headquartered in Chicago, Illinois. Dremel is a veteran medical technology executive with more than 27 years of experience in the development and commercialization of orthopedic products. He most recently served as general manager of Medacta USA’s Joint Reconstruction Division after joining the company in 2012. Previously, he spent nine years at DePuy Orthopaedics as vice president of sales..."

Read more on Bussinesswire

 

 

Medacta Highlights Knee, Hip, and Spine Surgery Best Practices at 7th International Symposium

Medacta Highlights Knee, Hip, and Spine Surgery Best Practices at 7th International Symposium

Medacta International today announced the opening of its 7th Medacta Orthopedic Research and Education (M.O.R.E.) International Symposium, which takes place this weekend near the company’s worldwide headquarters in Lugano, Switzerland.

Read more >

"Medacta International, a privately held, family-owned global leader in the design of innovative joint replacement and spine surgery products, today announced the opening of its 7th Medacta Orthopedic Research and Education (M.O.R.E.) International Symposium, which takes place this weekend near the company’s worldwide headquarters in Lugano, Switzerland. During the two-day event, more than 700 surgeon attendees will hear from a faculty of internationally recognized experts on topics including surgical best practices, emerging clinical data, and planned enhancements for Medacta knee, hip, and spine surgery products. The Symposium also coincides with a special milestone as Medacta celebrates its fifteenth anniversary and legacy as a patient-founded, patient-focused organization...."

Read more on Bussinesswire

Visit the 7th M.O.R.E. website

 

 

BFMTV: Medacta éclaire sur les meilleures pratiques de chirurgie du genou, de la hanche, et de la colonne lors du 7e symposium international, by

BFMTV: Medacta éclaire sur les meilleures pratiques de chirurgie du genou, de la hanche, et de la colonne lors du 7e symposium international, by

Témoigne de l'engagement sur le long terme pour la formation chirurgicale, l'éducation, et les résultats des patients -- Coïncide avec le quinzième anniversaire de Medacta et les derniers jalons des produits.

Read more >
Read more on BFMTV

 

ONVISTA.DE: Vorstellung von Erfolgsmethoden bei Knie-, Hüft- und Wirbelsäulenoperationen auf dem 7. internationalen Symposium von Medacta

ONVISTA.DE: Vorstellung von Erfolgsmethoden bei Knie-, Hüft- und Wirbelsäulenoperationen auf dem 7. internationalen Symposium von Medacta

Medacta setzt sich schon lange für chirurgische Aus- und Weiterbildung und bessere Ergebnisse für Patienten ein.

Read more >
Read more on ONVISTA.DE

 

INFORMAZIONE.IT: Medacta illustra le migliori pratiche per gli interventi chirurgici al ginocchio, all'anca e alla spina dorsale durante la 7ma edizione del suo simposio internazionale

INFORMAZIONE.IT: Medacta illustra le migliori pratiche per gli interventi chirurgici al ginocchio, all'anca e alla spina dorsale durante la 7ma edizione del suo simposio internazionale

L'evento rispecchia il suo impegno di lunga data rispetto alla formazione chirurgica, all'informazione e agli esiti per i pazienti -- L'evento coincide con la ricorrenza del quindicesimo anniversario di Medacta e con i traguardi conseguiti più di recente relativamente ai suoi prodotti

Read more >
Read more on INFORMAZIONE.IT

 

150th M.O.R.E. AMIS Learning Center

150th M.O.R.E. AMIS Learning Center

It is with great pride and pleasure that Medacta announces another milestone achievement for the M.O.R.E. Institute for AMIS® Education with the 150th AMIS® Learning Center which will take place on the 17th and 18th of March in Tours, France.

Read more >

It is with great pride and pleasure that Medacta announces another milestone achievement for the M.O.R.E. Institute for AMIS® Education with the 150th AMIS® Learning Center which will take place on the 17th and 18th of March in Tours, France. 
 

We would like to take a moment to celebrate this significant achievement and thank all the Surgeons who have supported us with their time, knowledge and passion for the educational activity that has made the AMIS® technique a new reference for Hip Replacement around the world.

With the 150th AMIS® Learning Center the M.O.R.E. Institute will be able to proclaim that over 1600 Surgeons have attended an AMIS® Course. In the meantime, over 2000 surgeon to surgeon visits have been made, supporting the start and routine use of the AMIS® technique in over 850 hospitals worldwide.

 

 

50,000 AMIStem femoral stems implanted worldwide!

50,000 AMIStem femoral stems implanted worldwide!

The first stem specifically designed for AMIS (Anterior Minimally Invasive Surgery), the AMIStem, has reached the impressive number of 50,000 implantations in only 4 years.

Read more >

The first hip stem designed to accommodate the anterior approach to the hip, the AMIStem Hip System, has recently achieved its 50,000th implantation since its launch in 2009.

When launched, the AMIStem System represented the first family of femoral components specifically designed to facilitate the anterior approach. Based on the proven clinical performance and design characteristics of the Quadra Hip System1,2, the AMIStem featured a reduced lateral shoulder and modified length.

This design evolution provided key advantages: an easier stem introduction due to the reduced lateral shoulder and the potential for reduced bone removal due to the overall reduced length of the stem. Like the Quadra stem, the AMIStem has proven very stable in both cementless and cemented versions3,4.

At 1 year, bone mineral density is equivalent for the two femoral stems5. In addition, AMIStem has proven to be a reliable solution for hip replacement6

 

[1] Thomsen M, Lee C, Jakubowitz E. Lab-Report Quadra-S, Medacta International SA: Measurement of the initial stability, Ortopädische Universitätsklinik Heidelberg, May 25 2006.
[2] Moreau P. Cementless HA Coated Quadra stem: 7 years clinical outcomes. M.O.R.E. Journal, 2 3-6, January 2012
[3] Bernardoni M, Siccardi F, Quagliana I, Grimoldi G. Mechanical stability of the AMIStem a standardized in-vitro analysis. M.O.R.E. Journal, 2011, May; Vol.1: 8-11.
[4] Bernardoni M, Siccardi F, Quagliana I, Camesasca S. Experimental assessment of the cemented AMIStem-C implant stability. M.O.R.E. Journal, 2012, January; Vol.2: 11-16.
[5] Petridis G, Scherer M, Gradinger R, Beck J, Nolde M. Periprosthetic bone mineral density after total hip arthroplasty with an AMIStem or Quadra femoral component performed by a minimally invasive anterior approach (AMIS): a prospective randomised clinical dual-energy x-ray absorptiometry study. Hip Int 2012; 22 (04): 477.
[6] Kalberer F. Stem design: the logical evolution. Podium presentation at the 6th M.O.R.E. International Symposium, Stresa, Italy, May 13-14, 2011.

First MyHip live surgery

First MyHip live surgery

We are pleased to communicate that the first live surgery of the MyHip Patient Matched Technology was performed by Prof. Dora in the Uniklinik Balgrist, in the 21st of November 2013, as part of the event “Orthopedics Update Kontroversen der endoprothetischen Hüftrekonstruktion: Was gibt‘s Neues?”, held by the Uniklinic Balgrist.

Read more >

 

The first live surgery of the MyHip Patient Matched Technology was performed by Prof. Dora in the Uniklinik Balgrist, in the 21st of November 2013, as part of the event “Orthopedics Update Kontroversen der endoprothetischen Hüftrekonstruktion: Was gibt‘s Neues?”, held by the Uniklinic Balgrist.

In the 21st of November 2013 occurred the first live surgery of the MyHip Patient Matched Technology, as part of an event held by the Uniklinik Balgrist named “Orthopedics Update Kontroversen der endoprothetischen Hüftrekonstruktion: Was gibt‘s Neues?”, which means “Orthopedics Update Controversies on hip replacement: What's new”. The surgery was performed with great success by Prof. Dora through the AMIS approach.

The MyHip technology is Medacta’s Patient Matched Technology for the hip joint, based on the success coming from the MyKnee system1. With the MyHip technology the surgeon can benefit from 3D pre-operative planning, that will purpose optimal implant placement and patient specific MyHip Femoral and Acetabular Guides that will aid a straightforward and accurate restoration of the patient’s natural hip function.


[1] Koch PP, Müller D, Pisan M, Fucentese SF. Radiographic accuracy in TKA with a CT-based patient-specific cutting block technique. Knee Surg Sports Traumatol Arthrosc, October 2013;10:2200-2205.

1st Revision AMIS Learning Center

1st Revision AMIS Learning Center

The 1st Revision AMIS Learning Center occurred during the 24-25th of October in Tours (France) with great success.

Read more >

 

The 1st Revision AMIS® Learning Center occurred during the 24-25th of October in Tours (France) with great success. 

The AMIS® Educational Program started in 2005. Medacta®, together with the AMIS® educational team, is committed to improving this program so surgeons worldwide can benefit from all advancements to the AMIS® approach. For that reason Medacta® has become the worldwide leader in anterior approach education, training more than 1500 surgeons globally since 2005 with 80% of the attendees continuing to use the AMIS® approach today.

In 2013, Medacta® introduced the Revision AMIS® Learning Center, furthering the potential of the anterior approach.

Medacta® truly believes that its commitment to education, combined with the support and experience of the AMIS® educational team, will benefit the orthopaedic community worldwide.

MyHip now available!

MyHip now available!

Take advantage of MyHip technology to further improve the precision of your Hip Replacement surgery.

Read more >

Take advantage of MyHip® technology to further improve the precision of your Hip Replacement surgery. 

With MyHip® Technology, the surgeon can benefit from precise 3D pre-operative planning that will propose optimal implant sizing and placement, as well as patient specific MyHip® Femoral and Acetabular Guides that will aid a straightforward and accurate restoration of the patient’s natural hip function. 

MyHip® for Precision on Demand.

 

*Contact your Medacta® representative for more information and for the availability/registration in your country. Not FDA cleared.

100,000 AMIS Procedure Performed Globally!

100,000 AMIS Procedure Performed Globally!

Over the last 9 years Medacta has actively promoted the AMIS (Anterior Minimally Invasive Surgery) Technique for Hip Arthroplasty. The result of this effort is that we can now proudly announce that in June 2013, we reached 100,000 AMIS procedures worldwide!

Read more >

Over the last 9 years Medacta® has actively promoted the AMIS® (Anterior Minimally Invasive Surgery) Technique for Hip Arthroplasty. The result of this effort is that we can now proudly announce that in June 2013, we reached 100,000 AMIS® procedures worldwide! 

The success of the AMIS® approach can be attributed to several factors. Along with the inherent benefits of the anterior approach (the only technique that follows a path both intermuscular and internervous considerably reducing the risk of damage to periarticular structures), the AMIS® approach has extensive clinical experience (as indicated by the 100,000 AMIS surgeries already performed), a detailed Educational Program (that improves the understanding of the anterior approach) and dedicated implants and instruments. All of these characteristics help to make the anterior approach simple, stable and reproducible. In addition, Medacta® has created patient specific educational material to fully inform potential hip replacement candidates of the benefits of AMIS®.
AMIS® offers a complete range of services which helps to keep Medacta® one step ahead, establishing us the recognized global leader in the promotion, standardization and education of the Anterior Approach.
However, our success would not be possible without the surgeons that work with us. To them, a big thank you for their support.

Versafitcup DM 10 years!

Versafitcup DM 10 years!

Versafitcup DM was introduced into the market in 2003 and we are pleased to announce 10 years of clinical success of this double mobility cup.

Read more >

 

Versafitcup® DM was introduced into the market in 2003 and we are pleased to announce 10 years of clinical success of this double mobility cup.

Since 2003, over 15,000 Versafitcup® DM implants have been used, proving it to be a reliable solution for hip arthroplasty, especially in cases where hip stability may have been a problem. Versafitcup® DM specifically addresses hip stability as it was designed to have the highest jumping distance in the market in order to decrease the risk of hip dislocation1. A recent study by Laffargue et al reported 0% of dislocation rate after 5 years and 99.2% survival rate using revision for any reason as the endpoint and 100% excluding septic failures2.

The Versafitcup® DM, together with the low dislocation rate, also provides an increased range of motion and a drastic reduction of PE wear, thus increasing its survival rate.     

The Versafitcup® DMs excellent performance and success could not be possible without the surgeons who work with Medacta®. We take this opportunity to thank them all!

 

1Spadini E, Quagliana I, Siccardi F, Bernardoni M, Ponzoni M. Impact of cup design in reducing the risk of dislocation. M.O.R.E. Journal, 2 17-21, January 2012

2Laffargue P, Roumazeille T, Soenen M, Migaud H. Versafitcup® double mobility cup: outcomes at a mean follow-up of 5 years. Poster presentation at the 12th EFORT Congress, Copenhagen, Denmark, 1-4 June 2011

 

Quadra-H 10 years!

Quadra-H 10 years!

In 2003 a new stem was introduced into the market: Quadra-H. This year we celebrate the 10th year of the Quadra-H stem system along with its clinical success.

Read more >

In 2003 a new stem was introduced into the market: Quadra®-H. This year we celebrate the 10th year of the Quadra®-H stem system along with its clinical success.

With more than 60,000 stems implanted worldwide it has proved to be a reliable solution for almost every indication of Hip Arthroplasty. From the mechanical tests performed the reports show excellent performance and stability of this stem design on bone1. In a 7 year clinical outcome study the Quadra®-H showed a 100% survival rate when considering aseptic loosening and a 97% survival rate when considering any reason as the endpoint2. It is an excellent straight cementless stem solution, which can also be easily implanted via the anterior approach. 

Many thanks to the surgeons who work with and support us for without them this success would not be possible.

 

1Thomsen M, Lee C, Jakubowitz E. Lab-Report Quadra-S, Medacta International SA: Measurement of the initial stability, Ortopädische Universitätsklinik Heidelberg, May 25 2006.

2Moreau P. Cementless HA Coated Quadra® stem: 7 years clinical outcomes. M.O.R.E. Journal, 2 3-6, January 2012

EFORT Fellowship Program supported by Medacta

EFORT Fellowship Program supported by Medacta

The EFORT FOUNDATION and Medacta International are pleased to announce that the Visiting EFORT Fellowship Program is now live! This is a good opportunity for Visiting Fellowships in the field of Total Hip and Total Knee Replacement, with particular focus on AMIS (Anterior Minimally Invasive Surgery) for THR and MyKnee (Patient Matched Cutting Blocks) for TKR.

Read more >

The EFORT FOUNDATION and Medacta® International are pleased to announce that the Visiting EFORT Fellowship Program is now live!

This is a good opportunity for Visiting Fellowships in the field of Total Hip and Total Knee Replacement, with particular focus on AMIS®
(Anterior Minimally Invasive Surgery) for THR and MyKnee® (Patient Matched Cutting Blocks) for TKR.

2013 applications are open to orthopaedic specialists in-line with their country's regulations at the following link:
http://www.efortfoundation.org/index.php/fellowships/visiting-fellowship-medacta/

Candidates can apply for a variety of terms as specified by the hosting center preferences.
Each grant is designed to cover the Fellow’s travel and living expenses for the duration of their stay.

All applications will be reviewed periodically by the EFORT FOUNDATION Evaluation Committee and the successful candidates will be notified in writing during the months of April, September and December, 2013.

10,000 MyKnee! This one works!!

10,000 MyKnee! This one works!!

The MyKnee® technology, developed by Medacta®, was first used in September 2009. Since then, 10,000 MyKnee® surgeries have already been done, a number reached in January 2013. This is a big proof of Medacta®’s PMT success.

Read more >

The MyKnee® technology, developed by Medacta®, was first used in September 2009. Since then, 10,000 MyKnee® surgeries have already been done, a number reached in January 2013. This is a big proof of Medacta®’s Patient Matched Technology (PMT) success.

This success has to be related with 2 main reasons: its specific characteristics and its proven accuracy and effectiveness.

MyKnee® offers a set of specific characteristics. These characteristics were added in order to improve the procedure’s benefits and success.

  • Actual cutting blocks, not only pin positioners
  • CT or MRI based, that allows surgeons to follow their preferences
  • Online interactive 3D planning, without any extra software needed
  • Complete in-house technology ensuring the assistance of a personal MyKnee® technician and only 3 weeks lead time!

A lot of studies have recently been published about MyKnee®1-11. In all of them the conclusions were consistently positive, pointing out that this specific PMT brings additional advantages and benefits to a Total Knee Replacement (TKR) procedure. With MyKnee®, the PMT claimed advantages are being achieved by its users.
“… perfect preoperative reliability and anatomical reconstruction”1
“… great advantage during the surgery”1
“… Reliable and straightforward technique…”2
“Instrumentation is reduced and OR efficiency is improved”3
“Surgeon, industry, and hospital revenue is potentially improved with the technique.”3
“The present study shows definitively that intraoperative resections and post-operative alignments can be accurately achieved with pre-operative CT planning and using patient-specific instrumentation.”4

 


1. Baldo F, Boniforti B, Patient-specific cutting blocks for total knee arthroplasty: preoperative planning reliability. J Orthopaed Traumatol (2011) 12 (Suppl 1): S23:S88
2. Müller D A, et al, CT based patient-specific cutting blocks for total knee arthroplasty: technique and preliminary radiological results. Podium Presentation at the 71st Annual Congress of the SSOT, Lausanne, Switzerland, June 22-24, 2011
3. Goldberg TD, MyKnee economical and clinical results. Podium presentation at the 6th M.O.R.E. Symposium, Stresa, Italy, May 13:14, 2011
4. Golberg T, et al, Clinical Outcomes of Patient-Specific (MyKeeTM) Cutting Blocks in Total Knee Arthroplasty: Preliminary Prospective Study Results, Poster in 12th Annual Meeting, June 13-16, Seoul, South Korea
5. Leon V, Patient matched technology vs conventional instrumentation and CAS. Poster at the 13th EFORT Congress, Berlin, May 23-25 2012
6. Koch P, et al, Guide de coupe sur mesure pour PTG: presentation de la technique opératoire et résultatsradiologiques préliminars. Podium presentation of the 86th annual congress of the SOFCOT, Paris, France, November 7-11, 2011
7. Dussault M, et al, Preoperative planning accuracy of MyKnee system. M.O.R.E. Journal 2012; 2:22-25
8. Trong M L D, et al, Patient specific cutting blocks improve accuracy of mechanical alignment in total knee arthroplasty, Poster in the 72. Congrés annuel de la Société Suisse d’Orthopédie et de Traumatologie, Basel, 27-29 June 2012
9. Goldber T D, MyKnee economical and clinical results. Podium presentation at the 6th M.O.R.E. International symposium, Stresa, Italy, May 13-14, 2011
10. Koch P, MyKnee system: A new vision in total knee replacement. Leading Opinions – Orthopädie & Rheumatologie 2, 2011:32-35
11. Gagna G, Aspect economiques de la tecnologie sur mesure MyKnee en chirurgie prothetique du genou, submitted to the SOFCOT 2012

MyKnee LBS is now available! The FIRST Patient Matched Cutting Blocks with integrated LIGAMENT BALANCING SYSTEM!

MyKnee LBS is now available! The FIRST Patient Matched Cutting Blocks with integrated LIGAMENT BALANCING SYSTEM!

Medacta® International is the only orthopedic company that offers this unique solution, the MyKnee® LBS: the FIRST Patient Matched Cutting Blocks with integrated LIGAMENT BALANCING SYSTEM.

Read more >

Medacta® International is the only orthopedic company that offers this unique solution, the MyKnee® LBS: the FIRST Patient Matched Cutting Blocks with integrated LIGAMENT BALANCING SYSTEM.

MyKnee® has already proved its accuracy and effectiveness[1-7] in the Bone Referencing Technique and now can also provide you the MyKnee® LBS option. MyKnee® LBS is the only patient matched system that allows the surgeon to accurately balance the soft tissue both in extension and in flexion before performing any femoral cut.

Read more about MyKnee®



[1] Baldo F et al, J Orthopaed Traumatol 2011, 12 (1):S23-S88.
[2] Leon V, 6th M.O.R.E International symposium, Stresa, Italy, May 13-14, 2011.
[3] Leon V, 13th EFORT Congress, Berlin, May 23-25, 2012.
[4] Koch P et al, 86th Annual Congress of the SOFCOT, Paris, France, Nov 7-11, 2011.
[5] Dussault M et al, M.O.R.E. Journal 2012, 2:22-25.
[6] Goldberg TD, 6th M.O.R.E International symposium, Stresa, Italy, May 13-14, 2011.
[7] Gagna G, submitted to the SOFCOT 2012.

KÄRNTNER NACHRICHTEN: Bei Hüftgelenken: AMIS – Methode führend

KÄRNTNER NACHRICHTEN: Bei Hüftgelenken: AMIS – Methode führend

Die minimal invasive Hüftchirurgie, wie sie seit rund 10 Jahren im Einsatz ist, hat die herkömmliche Hüftoperation revolutioniert

Read more >
KLEINE ZEITUNG: Lienzer leiteten Orthopädiekongress

KLEINE ZEITUNG: Lienzer leiteten Orthopädiekongress

Das Bezirkskrankenhaus Lienz und das ElisabethinenKrankenhaus in Klagenfurt sind Referenzzentren und Ausbildungsstätten für minimal invasive Hüftchirurgie und "my knee"-Endoprothetik. So bot sich Kärnten ideal für einen Kongress zur Hüft- und Kniechirurgie ideal an. In Pörtschach am Wörthersee diskutierten 150 Ärzte aus zehn Nationen drei Tage lang über die verschiedenen Perspektiven und Fragestellungen modernster orthopädischer Eingriffe. Die wissenschaftliche Leitung des Kongresses stand unter Patronanz der Lienzer Ärzte Valjdet Saciri und Herbert Strobl. Den Kärntner Teil deckten Manfred Kuschnig und Rupert Jesenko ab.

Read more >
OSTTIROL HEUTE: Lienzer Fachärzte leiteten Kongress in Pörtschach

OSTTIROL HEUTE: Lienzer Fachärzte leiteten Kongress in Pörtschach

Pörtschach am Wörthersee war drei Tage lang Schauplatz des internationalen Kongresses, bei dem 150 Ärzte über Hüft- und Knieendoprothetik diskutierten – Dr. Valjdet Saciri und Dr. Herbert Strobl, Fachärzte für Orthopädie am Bezirkskrankenhaus Lienz, hatten bereits zum 5. Mal die wissenschaftliche Leitung dieses hochkarätig besetzten Kongresses über. Die minimal invasive Hüftchirurgie, wie sie seit rund zehn Jahren im Einsatz ist, hat die herkömmliche Hüftoperation revolutioniert. Bereits zum fünften Mal steht diese AMIS©-Methode (anterior minimal-invasive surgery) im Vordergrund eines medizinischen Kongresses in Österreich.

Read more >
JATROS: AMIS & MyKnee Symposium Pörtschach

JATROS: AMIS & MyKnee Symposium Pörtschach

Minimal invasive Hüft-und Knieendoprothetik

Read more >
100th AMIS M.O.R.E. LEARNING CENTER

100th AMIS M.O.R.E. LEARNING CENTER

In March 2012 Medacta® hosted the 100th M.O.R.E. AMIS® learning center.
This milestone was celebrated with a special AMIS® advanced course in Paris.

Read more >

 

100th AMIS® Learning Center
23th - 24th March, 2012

Paris, France

 

100th AMIS® M.O.R.E. LEARNING CENTER
Medacta® leadership in education of the anterior minimally invasive approach.

In March 2012 Medacta® hosted the 100th M.O.R.E. AMIS® learning center. This milestone was celebrated with a special AMIS® advanced course in Paris.
The city of Paris is where the AMIS® adventure first began in 2004 and today the Medacta’s AMIS® Education Program provides the highest standard education package on the market for anterior minimally invasive Total Hip Replacement surgery. Medacta® has trained in excess of 1200 surgeons, with a success rate of 80% (surgeons proceeding with the AMIS® approach after training).
The 100th AMIS® Learning Center was conducted by the pioneers of AMIS®, namely, the European AMIS® Education Board. Participants included expert AMIS® surgeons and all of the worldwide AMIS® reference centers (80 worldwide, 60 in Europe).
The scientific programme included a large space for round table discussions, for all surgeons willing to add value with their experience and expertise.

This is another important achievement for Medacta®, and further confirmation of its leadership in the education of the anterior minimally invasive approach.

100'000 Medacta stems implanted worldwide, 70'000 are AMIS!

100'000 Medacta stems implanted worldwide, 70'000 are AMIS!

100'000 Medacta® stems implanted worldwide and the beginning of the Medacta® business in the Japanese and Brasilian orthopaedic market.

In March 2012, Medacta® announced the huge achievement of 100'000 hip stems implanted worldwide! 70'000 of these were implanted through the anterior minimally invasive approach, AMIS®.

Read more >

100'000 Medacta® stems implanted worldwide and the beginning of the Medacta® business in the Japanese and Brasilian orthopaedic market.

In March 2012, Medacta® announced the huge achievement of 100'000 hip stems implanted worldwide! 70'000 of these were implanted through the anterior minimally invasive approach, AMIS®.

Medacta® began business in the Japanese orthopaedic market, with the first Medacta® TKR surgery performed in Japan on December 6, 2011, and we can now announce the successful implantation of the first Medacta® THR in Brasil on April 3, 2012 and in Japan on May 1, 2012!

MyBaby

MyBaby

The company crèche MyBaby is committed to support parenthood, to promote the return of women back to their professional life after a maternity leave and to offer to users services of quality.

Read more >

                 

Il Nido Medacta® si impegna ad essere un servizio di sostegno ai genitori, a promuovere il rientro della donna nella vita professionale dopo la maternità, ad offrire ai propri utenti un servizio di qualità, in un ambiente accogliente e curato nel dettaglio.

I locali sono spaziosi e luminosi, ogni gruppo di età ha uno spazio proprio. E’ dotata di un’area esterna di 2000 mq con giardino di 200 mq e comodo parcheggio. E’ inoltre posizionata al termine di una strada a fondo cieco, pertanto la zona è silenziosa e con traffico automobilistico limitato.


Il Nido Medacta® sarà operativo a partire dal prossimo luglio 2012. Vi invitiamo a prendere contatto con la direttrice, la Sig.ra Ellen Metzger, che sarà felice di darvi informazioni, chiarimenti, o meglio di incontrarvi e mostrarvi i locali.

  Volantino MyBaby (610 Kb)
 

 

Visita il sito della nostra fondazione per scoprire altri interessanti progetti.

President's corner

President's corner

The pressure on selling prices in the orthopaedic field all over the world and the purchasing decision power that is slipping from surgeons to the healthcare administrators, is playing a contradictory role. On one hand the purchasing departments are more and more reluctant to pay the usual price for orthopaedic implant and on the other hand producing companies are actively trying to develop new products.

Read more >

The pressure on selling prices in the orthopaedic field all over the world and the purchasing decision power that is slipping from surgeons to the healthcare administrators, is playing a contradictory role. On one hand the purchasing departments are more and more reluctant to pay the usual price for orthopaedic implant and on the other hand producing companies are actively trying to develop new products.

In fact health administrations in the past have been facing high price innovations which have not always improved the clinical outcomes of patients or improved the economic impact of health cost of the country.
This fictitious and instrumental kind of innovation has created a suspicious attitude with health care administrators and often, with surgeons who did not accept to pay more for something novel which had no clinical advantages and furthermore was much more expensive.

Unfortunately now, the companies who want to introduce to the market innovative products which not only give much better clinical results but, thanks to their clever conception, decrease substantially the total cost of surgical procedures, rehabilitation and social and economical impact of the disease, are systematically and strongly rejected by the administrations of the hospitals.

Very often companies and surgeons, most aware of the advantages introduced by these new products, are confronted with the reluctance and intransigence of hospital administrators to adopt such innovations, condemning patients to long lasting hospitalisation and painful rehabilitation. Furthermore, against the dominant will to save cost, only few hospitals have the patience to deeply analyze their costs related to such innovation and eventually decide to adopt it.

Once again surgeons and orthopaedic companies must co-operate together in order to improve the quality and the quantity of their activities. They should not be afraid to drive innovation forward as the advantages will benefit patients and society in general.
Last but not least, by following this path, society will be able to count on the future development in the orthopaedic field, in both pursuing better economical and clinical results.

Companies have to develop a broader spectrum of communication that not only includes surgeons, nurses and patients but also hospital administrators and government health bodies. They have to develop a solid and proven plan of communication that addresses all the stakeholders involved. in this fundamental activity the role of surgeons is essential; only with their experience and help can companies see a viable future in the field of orthopaedics.

IT WORKS! Proven accuracy and effectiveness of MyKnee, patient matched cutting blocks

IT WORKS! Proven accuracy and effectiveness of MyKnee, patient matched cutting blocks

In 2009 Medacta® International launched MyKnee®, patient matched cutting blocks for knee replacement. Since then, several articles have been published on MyKnee® proving the two main benefits of patient matched technology: accuracy and effectiveness. 

Read more >

IT WORKS! Proven accuracy and effectiveness of MyKnee®, patient matched cutting blocks

Since 2008, all major orthopaedic companies have developed and actively promoted patient matched technology. The advantages of patient matched technology can be instantly identified just by its name!

Patient matched technology should take into account accurate positioning of the implant, thus potentially increasing its survival rate. The patient matched guides reduce the volume of instrumentation, helping the hospital to reduce the time and costs (up to 66% savings) associated with washing, assembling and sterilisation procedures. The overall OR efficiency is consequently increased, with a potential increase of the number of cases per surgery session.
 


 

This is all theory…
Which company can actually demonstrate these benefits with its patient matched system?
Analysing the literature available on patient matched technology, it is immediately apparent that there is a shortage of publications, the few publications that are available show controversial results[1-5].

In 2009 Medacta® International launched MyKnee®, patient matched cutting blocks for knee replacement. Since then, several articles have been published on MyKnee® proving the two main benefits of patient matched technology: accuracy and effectiveness[6-11].

MyKnee® proven benefits

Accurate MyKnee® limb alignment: 100% of the cases within 2° from 180°, analyses a series of postop CT’s [7].
MyKnee® is more accurate than conventional procedures and computer assisted surgery[6].
Reliable MyKnee® size planning: 98% size-matching[9].
With MyKnee®, the hospital’s turnover could be increased up to $230,000 per year [10].

What are the main reasons for MyKnee®’s success?
MyKnee® is the only patient matched technology on the market that offers the surgeon a unique set of benefits. MyKnee® provides patient matched cutting blocks, not just pin positioners, which can be created from a CT or MRI image. The outcome of 4000 MyKnee® cases treated to date, clearly demonstrates the supremacy of CT technology over MRI, due to the increased precision in the definition of the bone structure anatomy. In addition, special cases like TKR with the presence of plates or screws or UKR revision, impossible with an MRI, can easily be performed with CT based technology.

All of this is made possible in just 3 weeks (worldwide) including the assistance of a personal MyKnee® technician for each surgeon. Medacta® International develops and manufactures MyKnee® in-house, ensuring timeliness and precision – well known attributes of “Swiss Made”.

MyKnee® cases are managed entirely online without the need to download specialist software to analyse the 3D pre-operative planning and ensuring complete accessibility.

Medacta® always offers more…
Together with MyKnee® standard cutting blocks, Medacta® International offers you MyKnee® MIS cutting blocks.

The reduced size, rounded edges and anatomical shape allow the MyKnee® MIS cutting blocks to flawlessly adapt to minimally invasive approaches.
The soft tissues are respected and the added benefits are accuracy and efficiency.

Finally, MyKnee® lends its benefits to the UNI compartmental knee replacement via MyKnee® UNI*, designed to prepare the GMK® UNI* tibial resection and accurately plan the femoral size.
It has been demonstrated that there are several causes of early UKR failure which include inaccurate instrumentation[12]. Therefore the accurate and reproducible technique of MyKnee® UNI* is crucial to guarantee safe implant positioning and potential increased survival rate.

MyKnee® offers the surgeon a wide range of options which can be adapted to different surgical scenarios alongside personalised service, proven product accuracy and effectiveness.

 

References

[1] Webb J et al, 12th EFORT congress, Copenhagen, Jun 1-4, 2011.
[2] Parker D et al, AOA NZOA Meeting, Rotorua, New Zealand, Oct 9-14, 2011.
[3] Noble JW et al, J Arth 2012, 27(1):153-155.
[4] Misur P et al, AOA NZOA Meeting, Rotorua, New Zealand, Oct 9-14, 2011.
[5] Klatt BA et al, J Arth 2008, 23(1): 26-29.
[6] Leon V, 6th M.O.R.E International symposium, Stresa, Italy, May 13-14, 2011.
[7] Baldo F et al, J Orthopaed Traumatol 2011, 12 (1): S23-S88.
[8] Müller et al, 71st Annual Congress of the SSOT, Lausanne, Switzerland, Jun 22-24, 2011.
[9] Koch P et al, 86th Annual Congress of the SOFCOT, Paris, France, Nov 7-11, 2011.
[10] Goldberg TD, 6th M.O.R.E International symposium, Stresa, Italy, May 13-14, 2011.
[11] Koch P, Leading Opinions - Orth & Rheum 2011(2): 32-35.
[12] Kasodekar VB et al, Singapore Med J 2006; 47(9) : 796.
* GMK® UNI and MyKnee® UNI are not cleared by FDA for distribution in US.

VERSAFITCUP DM: the effective design to prevent dislocation

VERSAFITCUP DM: the effective design to prevent dislocation

Dislocation remains one of the most common causes of hip revision. Sariali[1] reports dislocation rates of between 0.5% and 10% for primary THA, increasing to between 10% - 25% following revision surgery. Following primary total hip arthroplasty, the treatment of dislocation is often expensive and, in the case of revision surgery, this cost can be as high as 148% of the hospital costs in comparison to an uncomplicated total hip replacement[2].

Read more >

Dislocation remains one of the most common causes of hip revision. Sariali[1] reports dislocation rates of between 0.5% and 10% for primary THA, increasing to between 10% - 25% following revision surgery. Following primary total hip arthroplasty, the treatment of dislocation is often expensive and, in the case of revision surgery, this cost can be as high as 148% of the hospital costs in comparison to an uncomplicated total hip replacement[2].
A predictive factor to evaluate effectiveness in dislocation prevention is the jumping distance, which can be defined as the lateral translation (AB) of the centre of the femoral head (τ) before dislocation occurs. F is the load force and ψ is the planar cup inclination angle measured in the frontal plane[3]. The lower the jumping distance, the higher the theoretical risk ofdislocation.

The jumping distance of the Versafitcup® Double Mobility (Medacta®) has been compared with other prosthesis designs aimed as solution for hip instability (cups with a design corresponding to a truncated hemisphere of 165°, such as M2a-MagnumTM (BIOMET)[4] and DUROM (Zimmer); dual mobility cups with a flat design or presenting an opening). Results are shown in the table below: the Versafitcup® Double Mobility has a cup design that provides effective hip stability and has produced better theoretical results than other designs on the market[5].


 

As an example, for heads (or liners in case of dual mobility design) size 48 we calculated the following jumping distance (JD) depending on the design: for Versafitcup® DM the JD is 22.7 mm, for a dual mobility cup with a flat design JD is 20.2 mm, for a dual mobility cup with opening JD is 17.8 mm and for a M-o-M cup (truncated hemisphere of 165°) the JD is 15.8 mm.

The Versafitcup® Double Mobility is the design with the largest jumping distance[5]. These results are reached due to the technical features of the Versafitcup® DM cup:

  • dual mobility design, the main responsibility for hip stability lies with the liner diameter and not the head diameter;
  • 5° raise, which increases the cover surface of the cup on the liner in the posterior part and enhances the inset value as a result;

  • offset of -4 mm, reducing the risk of dislocation when compared to other designs currently on the market.

 

The numerical results are supported and validated by clinical studies demonstrating that, after 5 years (minimum) follow-up of over 120 patients, there were no dislocations, no cup migrations, no loosening and no detectable wear[6].

 

References

[1] Sariali E, Leonard P, Mamoudy P, “Dislocation after total hip arthroplasty using Hueter anterior approach.” J Arthroplasty 2008; 23 (2): 266-72.
[2] Sanchez-Sotelo J, Haidukewych gJ, Boberg CJ. “Hospital Cost of Dislocation After primary Total Hip Arthroplasty.” J Bone Joint Surg, 2006 Feb, 88(2):290-4.
[3] Sariali E, Lazennec Jy, Khiami F, Catonné y, “Mathematical evaluation of jumping distance in total hip arthroplasty.” Acta orthopaedica 2009; 80 (3): 277-282.
[4] “Design Affects Performance of Metal-on-Metal Constructs.” BioMET orthopedics, Form No. Boi0325.0 RE V063011.
[5] Data on file Medacta®.
[6] Laffargue P, Versafitcup® “Double Mobility cup: outcomes at a mean follow-up of 5 years.” EFFoRT 2011, June 1st to 4th, Copenhagen (DK).

 

AMIS: Market Leader Worldwide for the Anterior Approach

AMIS: Market Leader Worldwide for the Anterior Approach

The anterior approach for total hip replacement is the only technique that follows an intermuscular and internervous path. An excellent reason why Anterior Minimally Invasive Surgery (= AMIS®) is the ideal approach for atraumatic surgery which is fundamental for a fast recovery.

Read more >

The anterior approach for total hip replacement is the only technique that follows an intermuscular and internervous path. An excellent reason why Anterior Minimally Invasive Surgery (= AMIS®) is the ideal approach for atraumatic surgery which is fundamental for a fast recovery. Other approaches, advertised as minimally invasive (posterior, lateral, or double incision), are associated with muscle and/or tendon injury and are therefore only reduced skin incision techniques.

AMIS®, strengthened by several years of clinical experience, provides the highest standard of service and innovation with regard to the anterior approach:

  • AMIS® specific instruments including the AMIS® Mobile Leg Positioner - the only anterior approach leg positioner with a PATENTED AUTOMATIC TRACTION RELEASE which ensures the optimal, safe and reproducible leg positioning during AMIS® surgery;
  • the AMIS® Education Program, the leading education package for anterior minimally invasive Total Hip Replacement surgery: surgeon is never alone during his first cases;
  • specific implants to increase the performance of the surgical procedure;
  • specific tools to educate patients and support the surgeon’s practice;
  • …and much more!

 

Would you like to perform the anterior minimally invasive approach?

Come and join us to discover the unique AMIS® world!

GMK KNEE REVISION SYSTEM: there are no impossible challanges

GMK KNEE REVISION SYSTEM: there are no impossible challanges

The upcoming global market launch of the GMK® Hinge*, the newest member of the GMK® family, will definitely enhance the Medacta® knee portfolio. GMK® Hinge* will help the surgeon manage more cases and take advantage of the additional clinical indications, including difficult primary cases and the most challenging knee revisions.

Read more >

The upcoming global market launch of the GMK® Hinge*, the newest member of the GMK® family, will definitely enhance the Medacta® knee portfolio. GMK® Hinge* will help the surgeon manage more cases and take advantage of the additional clinical indications, including difficult primary cases and the most challenging knee revisions.

The entire GMK® Total Knee Replacement System has been designed to preserve the joint functionality without dramatically altering its anatomy and kinematics, even in cases of severe ligament instability or massive bone defects.

Thanks to the GMK® Revision comprehensive range of options different levels of constraint, femoral and tibial augments, offset adapters and extension stems, the surgeon can choose the most suitable solution for every patient within his care.

The GMK® Hinge* inherits the same modularity concept as the GMK® Primary and GMK® Revision: the identical internal profile guarantees maximum intra-operative flexibility up to the final stages of the surgical procedure. This flexibility is enhanced by the instrumentation provided, making it simple and straightforward to switch intra-operatively from a non-constrained to a varus/valgus constrained or to a hinged implant.
 

GMK® Hinge* offers the patient even more advantages: a bone preserving design saves as much of the bone stock as possible, the modular hinge mechanism ensures the soft tissues are not stressed during implant assembly and the wide range of options ensure that the patient receives the best fitting implant without compromise. Additionally, the tried and tested modular connections always guarantee maximum safety and reliability.
 

The established GMK® implant, along with the easy to use instrumentation, help the surgeon to operate every day in total confidence, flawlessly addressing each surgical scenario: with the GMK® Knee Revision portfolio no challenge is impossible!

 

* GMK® HINGE is not cleared by the FDA for distribution in the US.

ELISABETHINEN-KRANKENHAUS KLAGENFURT: AMIS Ausbildung und Referenzzentrum Elisabethinen Krankenhaus Klagenfurt

ELISABETHINEN-KRANKENHAUS KLAGENFURT: AMIS Ausbildung und Referenzzentrum Elisabethinen Krankenhaus Klagenfurt

In der Medizin gilt es sich laufend über neue Methoden und medizinische Therapieformen zu informieren und sich diese anzueignen. In der Funktion eines Lehrkrankenhauses der Medizinischen Universität Graz werden seit Jahren am Elisabethinen-Krankenhaus in Klagenfurt Medizin-Studierende unterrichtet. „Aus- und Fortbildung wird in unserem Hause groß geschrieben. Neben unserem Lehrauftrag, den wir für die junge Ärzteschaft wahrnehmen, ist uns eine regelmäßige Weiterbildung unseres medizinischen und pflegerischen Personals sehr wichtig. Darüber hinaus schulen wir auch KollegInnen aus anderen Einrichtungen“, erläutert Primar Dr. Manfred Kuschnig, Medizinischer Direktor am Elisabethinen-Krankenhaus Klagenfurt und Leiter der Abteilung für Orthopädie. So geschehen im Rahmen des Ausbildungsprogramms der Amis®- Hüfttechnik (Anterior Minimally Invasive Surgery).

Read more >
HIGH TECH DAY AT SAINT GREGOIRE PRIVATE HOSPITAL

HIGH TECH DAY AT SAINT GREGOIRE PRIVATE HOSPITAL

Discover the quality and innovation that comes with the minimally invasive surgery coupled with the MyKnee technology! Experience the 1st MyKnee MIS live surgery from home. You can attend the online broadcast of MyKnee MIS live surgery from the comfort of your home, by simply registering on the website: www.vivaltotraining.com/canciani/index.php (registration is free!).

Read more >

HIGH TECH DAY AT SAINT GREGOIRE PRIVATE HOSPITAL Online broadcast of MyKnee MIS live surgery. Discover the quality and innovation that comes with the minimally invasive surgery coupled with the MyKnee technology! Experience the 1st MyKnee MIS live surgery from home. It was broadcast during the HIGH TECH DAY AT SAINT GREGOIRE PRIVATE HOSPITAL, held at the Saint Gregoire Private Hospital in Renne (France) and organized by Dr. Jean-Pierre Canciani from St.Gregoire Private Hospital, Vivalto Santé Education and Research and Medacta®. You can attend the online broadcast of MyKnee MIS live surgery from the comfort of your home, by simply registering on the website: www.vivaltotraining.com/canciani/index.php (registration is free!).

PIONEERING LIVE 3D ORTHOPAEDIC SURGERY

PIONEERING LIVE 3D ORTHOPAEDIC SURGERY

Great success of the 6th M.O.R.E. International Symposium on total hip and total knee replacement: PIONEERING LIVE 3D ORTHOPAEDIC SURGERY

Read more >

The 6th M.O.R.E. International Symposium on total hip and total knee replacement held at the Congress Palace in Stresa on 13th and 14th May 2011, was a great success. Medacta® International presented a high level scientific program which was attended by more than 400 delegates from around the globe (USA, Australia, Japan, South Africa, etc...). The faculty members included well known and highly respected international hip and knee surgeons.

The M.O.R.E. Institute (Medacta® Orthopaedic Research and Education), continues with education programs for orthopaedic surgeons, and its global success is enhanced by a network of national and international references. Medacta® currently offers more than 80 reference centers to support the education of surgeons worldwide.
Prof. Michael Freeman was Honorary Chair of The 6th M.O.R.E. International Symposium and Prof. Richard Santore and Dr. Peter Koch chaired the Hip Day and Knee Day, respectively.

 

HIP DAY
The hip day was oriented towards anterior minimally invasive hip surgery, of which Medacta®, with the AMIS® technique, is the Worldwide Market Leader.
A successful AMIS® (Anterior Minimally Invasive Surgery) approach results in less surgical trauma than other techniques for total hip replacement as it is the only technique that DOES NOT CUT MUSCLES AND DOES RESPECT NERVES. AMIS® may hasten patient recovery and reduce the post operative pain.

The symposium attendees witnessed live AMIS® Surgery performed by Prof. Fabio D’Angelo, with guest surgeon Dr. Frédéric Laude, from Ospedale di Circolo di Varese which was transmitted via satellite to the conference room of the Congress Palace in Stresa.

 

KNEE DAY
The innovative MyKnee® technology of patient matched cutting blocks, presented by Medacta® played the lead role of the knee day MyKnee® is a precision instrument which is tailored from a radiological image of the knee of each individual patient.
A successful MyKnee® technology means the intervention of kneearthroplasty is MORE ACCURATE, FASTER AND LESS TRAUMATIC.
During the symposium, Eng. Francesco Siccardi, Executive Vice President of Medacta®, spiked the interest of the attendees with the surprise announcement of THE LIVE 3D ORTHOPAEDIC SURGERY.

The MyKnee® surgery performed by Prof. Michele Surace, with guest surgeon Dr. Eric Milon, from Ospedale di Circolo di Varese was transmitted via satellite to the conference room of the Congress Palace in Stresa. The attendees were provided with 3D glasses to witness this important and unique event.

 

VERSAFITCUP HIGHCROSS - Double Mobility Liner

VERSAFITCUP HIGHCROSS - Double Mobility Liner

HIGH PERFORMANCES WITH NO DRAWBACKS
The Versafitcup® System increased its product range thanks to the introduction of the HighCross double mobility liner: the alternative to Metal-On-Metal Large Heads and Ceramic-On-Ceramic.

Read more >

HIGH PERFORMANCES WITH NO DRAWBACKS
The Versafitcup® System increased its product range thanks to the introduction of the HighCross double mobility liner: the alternative to Metal-On-Metal Large Heads and Ceramic-On-Ceramic. This new product combines all the advantages of Double Mobility design with the enhanced properties of cross-linked polyethylene:

  • The Double Mobility design includes different features giving important benefits: a low wear rate; a low dislocation rate; an increased Range of Motion.
  • The Highcross® material guarantees a low wear rate, reducing the risk of one of the main causes of implant failure: osteolysis due to polyethylene wear debris.

 

The Versafitcup® Highcross® Double Mobility Liner has important benefits when compared to conventional cup design:


1. Low dislocation rate (the diameter responsible for hip stability is the liner diameter, due to the retentive mechanism for the femoral head).


 

2. Low wear rate thanks to the Highcross® dual mobility and third articulation.


 

3. Big Range of Motion thanks to increased head/neck ratio.

  • Better than standard UHMWPe liners: - Further wear reduction thanks to Highcross technology.[2]
  • Better than Metal-on-Metal: No risk of metal ions release.
  • Better than Ceramic-on-Ceramic: No risk of liner fracture - No squeaking.

 

References

[1] Highcross® is the highly cross-linked UHMWPE from Medacta®.
[2] A.S. Greenwald, J.P. Garino. Alternative bearing surfaces: the good, the bad, and the ugly. J Bone Joint Surg 83-A, Suppl 2 Pt 2: 68-72, 2001.

 

MyKnee System: a new vision in total knee replacement.

MyKnee System: a new vision in total knee replacement.

INNOVATION: THE KEY TO SUCCESS
Medacta®'s core philosophy is based on the belief that innovation is the key to success. This leads to a constant effort towards the development of cutting edge solutions for Orthopaedics.
MyKnee® is a patient-specific cutting block, allowing the surgeon to realize his pre-o's knee.
This innovative concept combines different features giving potential benefits to both the surgeon and to the patient.

Read more >

INNOVATION: THE KEY TO SUCCESS
Medacta®'s core philosophy is based on the belief that innovation is the key to success. This leads to a constant effort towards the development of cutting edge solutions for Orthopaedics.
MyKnee® is a patient-specific cutting block, allowing the surgeon to realize his pre-o's knee.
This innovative concept combines different features giving potential benefits to both the surgeon and to the patient.

  • CT or MRI
  • Accurate implant positioning*
  • No intramedullary canal violation
  • Up to 60% reduction of surgical steps for bone resection
  • Potentially one extra case per surgery session
  • Up to 66% reduction of time and cost in washing, assembling and sterilization procedures
  • Online Interactive 3D planning

 

*Series of 56 cases - 90% neutral HKA within 3° from 180°, 100% HKA within 4.2° Koch P, Meyer D. Podium Presentation at the 21st Biennial Congress of the South African Arthroplasty Society, Cape Town, South Africa, April 6-10, 2011.

 

The anterior approach: the logical MIS approach

The anterior approach: the logical MIS approach

The AMIStem is the first stem specifically designed for the AMIS® approach (anterior minimally invasive surgery), engineered to offer bone preservation and easy introduction in the femoral canal.

Read more >

The AMIStem is the first stem specifically designed for the AMIS® approach (anterior minimally invasive surgery), engineered to offer bone preservation and easy introduction in the femoral canal.

 

Based on the Quadra® triple tapered design and Quadra® clinical experience[1], the AMIStem incorporates new features which simplify the AMIS® approach.

 

REDUCED TO THE MAXIMUM
The main aim in developing AMIStem has been to facilitate the broaching and stem introduction during the AMIS® approach without compromising the implant stability. The reduced lateral shoulder and the optimized length of the AMIStem minimize the amount of bone removed and decrease the space needed to introduce the stem by 33% in comparison with a standard straight rectangular stem design[2].

The result is an excellent AMIS®-friendly stem with a proven stability[3].

 

 

REDEFINING THR: THE AMIS® SYNERGY
The anterior approach, strengthened by several years of clinical experience, is the only technique which follows a path both intermuscular and internervous and therefore reduces considerably the risk of damaging periarticular structures such as muscles, tendons, vessels and nerves.
Thanks to its expertise, unique in the market, Medacta International is the worldwide leader for AMIS® (Anterior Minimally Invasive Surgery), with worldwide learning centers to teach the surgical approach, permanent support for surgeons starting with AMIS® and continuous development of specific AMIS® instrumentation.
With the use of AMIStem you will enter the Medacta® International AMIS® world.

Discover:

  • The definitive MIS approach: AMIS®;
  • The dedicated instrumentation for AMIS®;
  • The AMIS® Mobile Leg Positioner: the original orthopaedic table extension that mechanically assists throughout the procedure, making surgery easier and reproducible;
  • The dedicated AMIS® education program based on Medacta®'s extensive experience.

 

References

[1]Quadra cementless 3 years clinical follow up, Dr. Moreau, 2008. Data on File Medacta®.
[2]Data on File Medacta®.
[3]Heidelberg Lab-Report, Orthopädische Universitätsklinik Heidelberg, 2008. Data on file Medacta®.

VINZENZMAGAZIN: Moderne Knie-Chirurgie

VINZENZMAGAZIN: Moderne Knie-Chirurgie

Ein Wiener Orthopäde entwickelte die schnellere und präzisere Knieoperation „MyKnee“.

Read more >
JATROS: Anteriorer Zugang zum Hüftgelenk schont Muskulatur und Nerven

JATROS: Anteriorer Zugang zum Hüftgelenk schont Muskulatur und Nerven

AMIS: Anteriorer Zugang zum Hüftgelenk schont Muskulatur und Nerven

Read more >
SPIRIT: AMIS am Prüfstand

SPIRIT: AMIS am Prüfstand

AMIS am Prüfstand

Read more >
JATROS: Dr. Freithofnig AMIS eine Operation die wenig Spuren hinterlässt

JATROS: Dr. Freithofnig AMIS eine Operation die wenig Spuren hinterlässt

Ein Wiener Orthopäde entwickelte die schnellere und präzisere Knieoperation „MyKnee“.

Read more >